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CHAPTER I 
INTRODUCTION 
The fluidity of synaptic membranes has been shown 
to affect the activities of several membrane-associated 
enzymes. These include Na+K+-ATPase (Farias et al., 
1975; Alivisatos et al., 1977; Sandermann, 1978; Alivisatos 
et al., 1981) and adenylate cyclase (Rimon et al., 1978; 
Whetten et al., 1983). Membrane-associated functions of a 
number of neurotransmitter systems have also been shown to 
be modulated by membrane fluidity. The neurotransmitter 
systems include the serotonergic (Heron et al., 1980a,b; 
Heron et al., 1981), opioid peptide (Heron et al., 1980a; 
Heron et al., 1981), GABAergic (Toffano et al., 1981; Chweh 
& Leslie, 1982; North & Fleischer, 1983b), and cholinergic 
(Crews et al., 1983a; Freund et al., 1986) systems. 
Postnatal development, aging, and alcoholism are 
accompanied by changes in membrane-associated functions of 
several neurotransmitter systems (Freund, 1982; Meyer et 
al., 1984), an increase in the synaptic membrane cholester-
ol to phospholipid molar ratio, and decreased membrane 
fluidity (Crews et al., 1983b; Lyon & Goldstein, 1983; Nagy 
et al., 1983). It is possible that the changes in neural 
function are due, in part, to the changes in synaptic mem-
brane lipid composition and fluidity. 
1 
2 
To study this hypothesis, the influence of cho-
lesterol-induced changes in membrane fluidity on the 
dopaminergic system was investigated because the dopamin-
ergic system is sensitive to the effects of aging and 
alcohol (Roth, 1982; Hoffman & Tabakoff, 1985). The cho-
lesterol content of synaptic plasma membranes and synapto-
somes was altered using a lipid transfer protein from beef 
liver, which accelerates the exchange of cholesterol be-
tween liposomes and synaptic membranes. The fluidity of 
control and lipid-modified synaptic plasma membranes (SPM) 
was assessed by fluorescence polarization techniques, using 
l,6-diphenyl-1,3,5-hexatriene, to probe the hydrophobic 
core of the membrane, and l-anilinonaphthalene-8-sulfonic 
acid to probe the membrane surface. Control and lipid-
modified synaptosomes were assayed for [ 3H]-dopamine 
uptake, binding to the o1 receptor as assessed by the 
binding of [ 3H]-SCH23390, and maximal stimulation of 
adenylate cyclase activity by dopamine. The results ob-
tained from these studies may provide important informa-
tion about the influence of synaptic lipid composition and 
fluidity on receptor-mediated neural function. This data 
may provide a basis for understanding some of the age- and 
alcohol-related changes in neural function. 
CHAPTER II 
REVEIW OF THE RELATED LITERATURE 
MEMBRANE COMPOSITION AND FLUIDITY 
FACTORS INFLUENCING MEMBRANE FLUIDITY 
The fluidity of a biological membrane relates to 
the dynamic physical state of the fatty acyl chains of the 
phospholipids comprising that membrane bilayer {Stubbs, 
1983). Factors that influence membrane fluidity include: 
the unsaturation and chain length of fatty acids, the 
change in frequency of trans-gauche isomerizations of c-c 
bonds of the methylene groups in phospholipid fatty acyl 
chains, and the rate and range of motion in phospholipid 
fatty acyl chains. Also important are the lateral and 
rotational mobility of phospholipids, changes in phospho-
lipid head group conformations, changes in the interaction 
of cholesterol with membrane lipids, and the change in the 
interaction of proteins with lipids (Shinitzky & Barenholz, 
1978; Houslay & Stanley, 1982; Stubbs, 1983; Stubbs & 
Smith, 1984). 
The degree of unsaturation and chain length of the 
fatty acids (FA) in phospholipids are important in membrane 
fluidity. A decrease in the double bond index:saturated 
ratio, defined as: 
3 
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(mole % unsaturated FA X # double bonds) 
/.; mole % saturated FA (eq. 1) 
(Stubbs, 1983) has been used as a chemical measure of 
membrane fluidity (Farias et al., 1975). This assumption 
is valid when other parameters, such as cholesterol/phos-
pholipid molar ratio (Chol/PL), remain constant and the FA 
double bonds have the same cis configuration (Castuma & 
Brenner, 1983). studies using biological membranes indi-
cate that a significant change in the degree of unsatura-
tion of FA results in only small changes in the motion of 
the FA chains as measured using electron spin resonance 
(ESR) and fluorescence techniques (Stubbs & Smith, 1984). 
Phospholipid head groups have a complex effect on 
membrane fluidity. In model membranes, phospholipid bi-
layers prepared from individual classes of saturated phos-
pholipids, the transition temperatures vary from o0 c in 
phosphatidylcholine (PC) membranes to 3o0 c in sphingo-
myelin (SP) membranes. It is evident that the head group 
influences acyl chain motion, but the biological importance 
is unclear because of the variability in the fatty acid 
composition between the classes of phospholipids found in 
biological membranes (Stubbs, 1983). 
Membrane-bound proteins have an immobilizing 
effect on the lipids that surround them (boundary lipids) 
(Stubbs, 1983). The fluidity of lipids in the region of 
proteins can be studied using nuclear magnetic resonance 
(NMR) techniques with deuterated phospholipids. This is 
5 
not very efficient, however, because the labelled boundary 
lipids readily exchange with bulk lipid. Because of the 
nature of their probes, ESR and fluorescence spcectroscopic 
techniques give no information about the fluidity of this 
boundary lipid region (Feinstein et al., 1975; Stubbs, 
1983). 
Cholesterol, a major lipid of plasma membranes of 
most cells (Stubbs, 1983), is a principal modulator of mem-
brane fluidity. With its rigid, planar, wedge-shaped 
structure, cholesterol orients perpendicular to the mem-
brane surface, with its hydroxyl group near the carbonyl of 
FA (Houslay & Stanley, 1982; Stubbs, 1983) (Figure 1). 
Cholesterol has the ability to condense phospholipid 
bilayers, making them less permeable to small molecules. 
Various physical techniques have demonstrated that cho-
lesterol has a small fluidizing effect below the phase 
transition temperature (gel phase), and a large rigidifying 
effect above this temperature (Figure 2) (Van Blitterswijk 
et al., 1981; Stubbs, 1983). Cholesterol diminishes the 
enthalpy change at phase transition. The presence of large 
amounts of cholesterol in the membrane removes the phase 
transition characteristics. Cholesterol appears to act as 
a buff er against large changes in the bulk physical prop-
erties of the membrane produced by other agents such as 
alcohol (Stubbs, 1983). In most cases, the viscosity 
(inverse of fluidity) of a biological membrane reflects its 
0 
II lHNdvrouP~0-P-0-CH1 O -I I \\ 
_Q HC-0-C 
Motion 
re11rocted - - un•flett•d -
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Figure 1. Interaction of Cholesterol with Phospho-
Lipids in a Lipid Bilayer. 
(Houslay and Stanley, 1982) 
CRYSTALLINE 
STATE LIQUEFYING 
T <Tc 
J 
ENDOTHERMIC 
TRANSITION 
LIQUID 
CRYSTALLINE ' CONDENSING 
STATE 
T >Tc 
Figure 2: The Effect of Cholesterol on Membrane 
Phospholipids Above and Below the 
Transition Temperature. 
The arrows point to cholesterol within the 
bilayer. Above the transition temperature (Tc), 
cholesterol will condense phospholipid bilayers, 
reducing their permeability to small molecules. 
Below the transition temperature, cholesterol 
liquifies the bilayer, allowing more freedom of 
movement of the fatty acyl side chains. 
(VanBlitterswijk et al., 1981) 
7 
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Chol/PL, although these cholesterol effects are influenced 
by the FA composition of phospholipids and charged groups 
at the membrane surface (Feinstein et al., 1975). 
TECHNIQUES FOR MEASURING MEMBRANE FLUIDITY 
NMR. In nuclear magnetic resonance (NMR) studies, 
deuterated lipids are incorporated into the membranes to be 
studied. Although this method produces the least perturba-
tion of the membrane structure (Stubbs & Smith, 1984), it 
has several drawbacks. The sensitivity is low, expensive 
equipment is required, and special deuterated phospholipids 
must be synthesized in large quantities. Also, the assump-
tions used to derive the rate of motion and the calcula-
tions are very complex and reportedly less reliable than 
those utilized in fluorescence studies (Stubbs, 1983). 
ESR. Electron spin resonance (ESR) of a nitroxide 
probe can provide information about the mobility of the 
probe, the orientation of the probe in its environment, the 
order of the system, and the lateral diffusion of the probe 
in the plane of the membrane (Jain & Wagner, 1980). The 
drawbacks of ESR are similar to those of NMR in that the 
equipment is expensive and the spin-labelled probes must be 
synthesized. Unlike NMR, ESR probes, because of their 
unpaired electron, can perturb the membrane. 
FLUORESCENCE POLARIZATION. Fluorescence polariza-
tion is based on the phenomenon that when a fluorophore is 
excited by light, it absorbs the light energy and emits 
9 
photons of lower energy. This technique can be adapted to 
give information on the orientation or range and rate of 
motion of the fluorophore and its adjacent environment 
(Bentley et al., 1985). 
In order to understand the basic principles of 
fluorescence polarization, several phenomena involved in 
the fluorescence of a molecule should be described (Bentley 
et al., 1985). First, an interval of time exists between 
the absorption and fluorescent emission of light. This 
interval is the fluorescence lifetime and is usually in the 
nanosecond range. Second, the emitted light is not re-
leased in a random direction, but is oriented in a direc-
tion determined by the transition moment of the excited 
molecules, the direction in which the molecule most easily 
absorbs light. Light is preferentially absorbed when the 
electrical vector of the exciting light is parallel to the 
transition moment of the molecule. The electric vector of 
the emitted light will also be parallel to the transition 
moment of the excited molecule. 
When a molecule is excited with polarized light, 
the electric vector of the emitted light will be parallel 
to the electric vector of the exciting light if the mole-
cule remains stationary during the lifetime of the excited 
state (Bentley et al., 1985; Shinitzky & Barenholz, 1978). 
Rotation of a molecule during its excited state will depo-
larize the emitted light with respect to the exciting 
10 
beam. As the molecular motion in a system increases, the 
emitted light will be increasingly depolarized (Bentley et 
al., 1985; Shinitzky & Barenholz, 1978). 
Fluorescence polarization values (P) are measured 
by exciting a molecule with polarized light and observing 
the intensity (I) of the emitted light oriented parallel 
and perpendicular to the direction of the electric vector 
of the exciting light. P is calculated by the equation: 
p == ( eq. 2) 
1 11 + Ii 
(Bentley et al., 1985; Shinitzky & Barenholz, 1978). 
Experimentally, polarization measurements are made 
by determining the fluorescence intensity reading with the 
excitation and emission polarizers in combinations of ver-
tical (v) and horizontal (h) positions. The possible com-
binations are vv, vh, hh, hv, where the letter order rep-
resents the excitation and emission polarizers respective-
ly. I
1 
and Il in equation 2 correspond to the settings vv 
and vh respectively. The hh and hv settings are used to 
correct for artifacts introduced by the instrument. In 
practice, P is calculated by the equation: 
( eq. 3) 
Ivv + Ivh (Ihv/Ihh) 
Polarization data can be expressed as polarization 
(P) values as described in equations 2 and 3, or as aniso-
tropy (r) values: 
Ii - I..1. I, 
r = 
I 11 + 2I..1. 
(Shinitzky & Barenholz, 1978). 
11 
( eq. 4) 
P values can be converted to r values by the 
equation: 
2P 
r = ( eq. 5) 
3-P 
(Shinitzky & Barenholz, 1978). 
The relative microviscosity of the membrane can be 
calculated from the r values by the equation: 
1 
relative microviscosity = ~~~~- (eq. 6) 
(r0/r)-l 
(Shinitzky & Barneholz, 1978). The term r 0 refers to the 
limiting anisotropy and is experimentally determined for 
each fluorescent probe. For DPH, r 0 = 0.362 (Shinitzky & 
Barenholz, 1978). For ANS, r 0 = 0.346 (Weber & Daniel, 
1966) • 
FLUORESCENT PROBES 
DPH. l,6-Diphenyl-1,3,5-hexatriene (DPH) (Figure 
3a) is a polyene hydrocarbon with a stable all-trans con-
figuration of an elongated rectangular shape (Shinitzky & 
Barenholz, 1978). It partitions easily into membranes, 
orienting itself perpendicular to the plane of the membrane 
(Stubbs & smith, 1984) (Figure 3c). DPH does not fluoresce 
Figure 3 12 
a) Structure of DPh b) Structure of ANS 
c) Orientation of DPH and ANS in a Phospho-
Lipid Bilayer. 
(Jost and Griffith, 1980) 
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in an aqueous environment (Stubbs & Smith, 1984). Its 
quantum yield increases when the environment becomes hydro-
phobic, and continues to increase as the viscosity in-
creases, approaching 1 (Shinitzky & Barenholz, 1978). The 
excitation and emission maxima (360 nm and 430 nm, respec-
tively) (Litman & Barenholz, 1982) remain constant, regard-
less of the phase or composition of the membrane (Shinitzky 
& Barenholz, 1978). When cholesterol is incorporated into 
a phospholipid bilayer, the DPH polarization values are 
greater than those in the absence of cholesterol. The in-
crease in DPH polarization has been correlated to an in-
crease in Chol/PL (Van Blitterswijk et al., 1984). These 
properties make DPH an almost ideal probe for the hydro-
phobic region of the membrane (Stubbs & Smith, 1984). 
ANS. l-Anilinonaphthalene-8-sulfonic acid (ANS) 
(Figure 3b) is a negatively charged molecule that, in the 
membrane, localizes in the region of the phospholipid polar 
head, with its aromatic rings at the level of the FA car-
bonyl, and its sulfonate group directed outward (Figure 3c) 
(Slavik, 1982). The magnitude of the fluorescence signal 
from ANS in aqueous solvents is low, but increases as the 
solvent becomes less polar. The probe prefers to interact 
with the choline-containing head groups of phosphatidyl-
choline (PC) and sphingomyelin (SP). Although the positive 
charge of these groups plays a role in the binding of ANS, 
the interaction is not entirely electrostatic in nature as 
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phosphatidylethanolamine (PE), which is also positively 
charged, does not bind ANS. As the Chol/PL increases 
within the membrane, the ANS is pushed closer to the sur-
face of the membrane, which makes it more accessible to the 
aqueous environment, and which decreases the quantum yield 
(Slavik, 1982). 
Although ANS is sensitive to the changes in its 
environment near the membrane surface, it also binds non-
covalently to proteins within the membrane. This can make 
it difficult to interpret fluorescence polarization data if 
it is not properly acquired. ANS binding to proteins is of 
very high affinity, but the number of binding sites is 
low. The excitation and emission maxima are 380 nm and 480 
nm, respectively. The lipid binding sites are of lower 
affinity, but are more abundant than those on the pro-
teins. The excitation and emission maxima for these sites 
are 395 nm and 490 nm respectively. When low concentra-
tions of ANS are used (1 µM), ANS binds primarily to pro-
teins. At high concentrations (200 µM), the fluorescence 
reflects ANS bound predominantly to lipids (Slavik, 1982). 
Under the appropriate conditions, ANS can be a useful probe 
of the membrane surface. 
MEMBRANE FLUIDITY DURING DEVELOPMENT 
As the brain develops, the lipid composition of 
synaptic plasma membranes (SPM), and hence the fluidity of 
SPM, have been observed to undergo a series of alter-
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ations. Hitzemann (1981) studied the FA in rat cortical 
SPM phospholipids as a function of postnatal age (7 days, 
14 days, and adult). Overall, between day 7 postnatal and 
adult, there was a trend toward increased polyunsaturated 
long chain FA and decreased short chain saturated FA. Spe-
cific changes are detailed below. The double bond index-
saturated ratio (equation 1, page 4) increased from day 7 
to day 14, followed by a slight decrease from day 14 to 
adult. (Hitzemann & Johnson, 1983). In PC, the major phos-
pholipid, decreases were observed in 14:0, 16:1, and 22:5 
FA, with increases in 18:0, 22:6, and the largest increase 
in the ratio of 22:6 to 22:5 (22:6/22:5) (281%). In PE, 
18:0 increased from day 7 to 14 and decreased from day 14 
to adult. Incr~ases were also observed in 22:6, 22:4, and 
the 22:6/22:5 ratio (104%) associated with PE. Ethanol-
amine plasmalogen (EP) showed an increase in 22:4, a 
decrease in 22:5, and an increase in the 22:6/22:5 ratio. 
SP showed a decrease in 16:0 and an increase in 18:0. In 
phosphatidylinositol (PI), 16:0 and 18:0 were decreased 
while 20:4 was increased. Phosphatidylserine (PS) showed 
the opposite trend. Decreases were observed in 20:4, 22:4, 
and 22:5. A transient increase in 22:6 was observed along 
with increases in 16:0 and 18:0. Taken alone, these 
changes would not be sufficient to produce a significant 
change in membrane viscosity. 
Further studies of age-related changes in synaptic 
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membrane composition during development (Hitzemann & 
Johnson, 1983) focused on the observed molar Chol/PL, 
protein to lipid ratio, SP content, degree of phospholipid 
methylation, and ganglioside content, along with steady-
state anisotropy of DPH fluorescence of the intact SPM as 
well as bilayers prepared from lipid extracted from these 
membranes. The results of these studies demonstrated an 
increase in fluorescence polarization of intact membranes 
and lipid bilayers during development, and hence a decrease 
in fluidity (increase in viscosity) with age. The sterol/ 
phospholipid ratio in adult rats was increased as compared 
to both 7 day and 14 day membranes. These changes would 
produce an increase in the viscosity of the membrane. The 
protein/phospholipid ratio increased after day 14. This 
suggested that the fluidity change observed from day 7 to 
day 14 was due to changes in the lipid components of the 
membrane (Hitzemann & Johnson, 1983). 
There is a developmental decrease in choline phos-
pholipids, primarily due to a decrease in PC. Ganglioside 
levels were not changed during development (Hitzemann & 
Johnson, 1983). Thus, it is seen that during development, 
the decrease in membrane fluidity is primarily due to 
increases in Chol/PL and the protein to lipid ratio, as 
well as a decrease in PC. 
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MEMBRANE FLUIDITY DURING AGING 
In order to maintain the normal function of bio-
logical membranes, it is important to maintain the fluidity 
of those membranes within a narrow range. This is referred 
to as membrane fluidity homeostasis (Shinitzky, 1984). 
This is believed to occur through enzymatic processes which 
change the degree of unsaturation of FA in phospholipids 
and/or which lead to the esterif ication of excess membrane 
cholesterol. Lipid changes observed in aging have been 
suggested to be due to a weakening of the processes which 
maintain homeostasis (Shinitzky, 1984). 
Early studies of membrane fluidity utilized hom-
ogenates of whole brain and brain regions. With increasing 
age, an increase in viscosity was observed in all brain 
regions studied (Samuel et al., 1982). Total protein and 
cholesterol were increased in whole brain homogenate 
(Calderini et al., 1983) as well as the Chol/PL in hom-
ogenates prepared from hippocampus, caudate, and cerebral 
cortex (Samuel et al., 1982) from 24 month old rats, as 
compared to 3 month old rats. These studies did not 
attempt to correlate whole brain changes with particular 
neural membranes, such as SPM or myelin. 
Using DPH (Shinitzky et al., 1983; Calderini et 
al., 1983) and 16-doxyl stearic acid (Nagy et al., 1983) to 
probe the hydrophobic core of the membrane, it was found 
that the viscosity of synaptic membranes in aged mice (24-
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28 months) (Shinitzky et al., 1983) and rats (24 months) 
(Calderini et al., 1983; Nagy et al., 1983) was increased 
as compared to that of young animals (2-3 months). This 
increased viscosity was accompanied by an increase in 
Chol/PL of up to 30% in aged animals (Shinitzky et al., 
1983; Armbrecht et al., 1983). 
It has been suggested (Hitzemann, 1984) that an 
incremental increase in cholesterol will have a small ef-
fect on membrane viscosity if the membrane normally con-
tains a relatively high amount of cholesterol (Chol/PL = 
0.5), as is the case with SPM. Therefore, additional fac-
tors must be involved in the observed increase in viscos-
ity found in aging. 
MEMBRANE FLUIDITY AND ETHANOL 
Ethanol, added in vitro, will increase the 
fluidity of synaptic membranes as assessed using ESR probes 
(Chin & Goldstein, 1977a,b; Chin & Goldstein, 1981; 
Goldstein et al., 1982; Armbrecht et al., 1983; Logan et 
al., 1983). Many such studies used high, and non-
physiological ethanol concentrations (up to 500 mM) 
(Armbrecht et al., 1983; Logan et al., 1983). However, 
ethanol has demonstrated a fluidizing effect at concen-
trations as low as 10 mM ethanol (50 mg%) (Chin & 
Goldstein, 1977a) and produced a dose-related change in 
fluidity between 10 mM and 350 mM ethanol (Chin & 
Goldstein, 1977a). 
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Chronic ethanol administration produces a type of 
membrane tolerance in synaptic and other cellular mem-
branes. Although no change in baseline fluidity of the 
membranes was observed, in studies using DPH (Beauge et 
al., 1984) and 5-doxyl stearic acid (Chin & Goldstein, 
1977b) as probes, the membranes from the ethanol-treated 
animals were resistant to the fluidizing effects of ethanol 
(Chin & Goldstein, 1977b; Johnson et al., 1979; Beauge et 
al., 1984). In addition, using a 12-doxyl stearic acid 
probe, which measures the fluidity deeper within the mem-
brane, a decrease in the baseline fluidity was detected in 
the interior of membranes from ethanol-treated animals 
(Lyon & Goldstein, 1983). Also, the partition coefficient 
of ethanol into synaptosomes from ethanol-treated animals 
was 66% lower than into control membranes (Rottenberg et 
al., 1981; Rubin & Rottenberg, 1983). 
The composition of synaptic membranes from control 
and ethanol treated rats and mice has been studied by many 
investigators. The results obtained appear to be dependent 
on the method of administration of ethanol, as well as the 
duration and dose administered. Synaptic membranes from 
Sprague Dawley rats given intragastric doses of 20% aqueous 
ethanol (Crews et al., 1983b), C57/BL6 (Smith & Gerhart, 
1982) and DBA/2J (Chin et al., 1978) mice fed liquid diets 
containing 7% and 33% ethanol, respectively, were found to 
have an increase in the Chol/PL as compared to controls. 
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This was due to an increase in cholesterol content (choles-
terol/mg protein) with no change in phospholipids. The 
magnitude of the increase in Chol/PL was up to 30% over the 
control, which could be considered the physiological limit 
of the Chol/PL. The FA composition of the phospholipids 
was not changed by the chronic ethanol administration (Chin 
et al., 1978; Smith & Gerhart, 1982; Crews et al., 1983b). 
When ethanol was administered to T0 Swiss mice 
by inhalation, different results were obtained (Littleton & 
John, 1977; Littleton et al., 1979). No change in choles-
terol content or Chol/PL was observed. However, there was 
an increase in 18:0 FA and a decrease in 20:4 FA (Littleton 
& John, 1977; Littleton et al., 1979), producing a decrease 
in the double bond index:saturated ratio (equation 1, page 
4). The discrepancy in the results may be due to the me-
thod of administration of ethanol. Inhalation may be a 
more severe technique, producing and maintaining high 
ethanol concentrations in the brain. It is possible that 
alterations in the FA composition can be implemented more 
quickly than alterations in cholesterol content. Use of 
liquid diets and intubation produces lower blood and brain 
ethanol concentrations. 
Both an increase in Chol/PL and a decrease in the 
double bond index:saturated ratio could be responsible for 
the tolerance observed. To study this further, Johnson et 
al. (1979) extracted the lipids from synaptic membranes of 
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control ICR mice and those treated chronically with ethanol 
by intraperitoneal injection. The lipids were reconsti-
tuted and the fluidity determined using DPH as probe. The 
lipids from the ethanol-treated animals were less fluidized 
by ethanol and had a lower intrinsic fluidity than con-
trols. When cholesterol was removed from the reconstituted 
lipids, the change in fluidity in response to in vitro 
ethanol was indistinguishable in the ethanol-treated and 
control groups. When cholesterol was added to the recon-
stituted lipids so that the Chol/PL of the lipids from the 
control and ethanol-treated groups were equal, the differ-
ence in response to in vitro ethanol returned, although 
there was no difference in the intrinsic fluidity of the 
reconstituted lipids. This study suggests that cholesterol 
is involved in tolerance, but is not solely responsible for 
it (Johnson et al., 1979). 
DOPAMINE BINDING 
DOPAMINE RECEPTOR SUBTYPES 
There appears to be some disagreement in the lit-
erature as to the number of dopamine receptor subtypes 
present in rat brain. Seeman & List (1981) describe four 
receptor subtypes based on their affinities for dopamine 
(an agonist) and spiperone (an antagonist). D1 recep-
tors, localized postsynaptically, have a low affinity for 
dopamine and spiperone (3000 nM and 2000 nM respectively) 
and are linked to the stimulation of adenlyate cyclase. 
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o2 receptors, also localized postsynaptically, have a low 
affinity for dopamine (5000 nM) but a high affinity for 
spiperone (0.3 nM). The o2 receptors are thought to be 
responsible for the behavioral effects of neuroleptic 
drugs. D3 receptors, found both pre- and postsynaptic-
ally, have a high affinity for dopamine (3 nM) but a low 
affinity for spiperone (1500 nM). o4 receptors, possibly 
localized postsynaptically, have a high affinity for both 
dopamine and spiperone (20 nM and 0.1 nM respectively) and 
are linked to dopamine-inhibition of adenylate cyclase ac-
tivity. The existence of the D3 and o4 receptor sub-
types is disputed by Creese et al. (1983), who suggest that 
the D3 and D4 receptors are high agonist-affinity 
states of the D1 and D2 receptors, respectively. 
MEASURING DOPAMINE BINDING PARAMETERS 
Several ligands are presently available to study 
dopamine receptors. The most widely used is spiroperidol 
(spiperone), a dopamine antagonist. Spiperone, at nano-
molar concentrations, is known to bind to serotonin as well 
as dopamine receptors (Creese et al., 1977; Creese & 
Snyder, 1978). In bovine caudate (Creese et al., 1977) and 
rat striatum (Hamblin et al., 1984), where the density of 
serotonin sites is low, spiperone binds primarily to dopa-
mine sites. Because the D1 receptor has a much lower 
affinity for spiperone than does the D2 receptor, binding 
studies utilizing low spiperone concentrations will detect 
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primarily the higher affinity o2 sites (Hamblin et al., 
1984). At higher concentrations, binding to both the o1 
and o2 sites is suggested by nonlinear Scatchard plots. 
To quantitate the o2 sites, the o2-specific 
antagonists, domperidone and sulpiride, have been used 
(Hamblin et al., 1984). Antagonist/[ 3HJ-domperidone 
competition curves suggest the presence of a single o2 
dopamine receptor. Whereas, agonist/ [ 3H]-domperidone 
competition curves suggest the presence of high and low 
agonist-aff inity states of the o2 receptor (Hamblin et 
al., 1984). 
The partial dopamine agonists, apomorphine and 
ADTN (2-amino-6,7-dihydroxyl-1,2,3,4-tetrahydronaphthalene) 
label both o1 and o2 receptors in rat striatum. These 
ligands stimulate adenylate cyclase through the o1 recep-
tor. They are also displaced by low concentrations of 
spiperone, characteristic of binding to the o2 receptor 
(Creese et al., 1978; Creese & Snyder, 1978b). Both of 
these ligands exhibit decreased binding in the presence of 
guanine nucleotides. 
The o1 receptor has been difficult to character-
ize because of its low affinity for agonists and spiperone 
(Seeman & List, 1981). The first high affinity o1 ligand 
to be characterized was cis-flupenthixol, a dopamine 
antagonist (Hyttel, 1978; Cross & Owen, 1980; Hyttel, 1980; 
Leff et al., 1985). In the presence of low concentrations 
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of spiperone (10 nM) to block binding to n2 receptors, 
cis-flupenthixol binding to n1 receptors was studied in 
rat striatum (Hyttel, 1978; Hyttel, 1980; Leff et al., 
1985) and bovine caudate membranes (Cross & Owen, 1980). 
However, high nonspecific binding (up to 70%) (Leff et al., 
1985), makes cis-flupenthixol a poor choice for a n1 
ligand. 
n1 receptors are specifically labelled with the 
o1 antagonist, SCH23390. In vitro binding studies reveal 
a single class of high affinity sites in rat striatum, with 
a Kd of 0.14 nM (Anderson & Nielsen, 1986). However, 
from in vivo studies, the Kd is calculated as 12.3 nM, 
which is similar to the Ki for SCH23390 inhibition of 
dopamine-sensitive adenylate cyclase in vitro (Anderson & 
Nielsen, 1986). Thus, in the in vitro studies using 
SCH-23390 reflect the kinetics involved in the first step 
in the activation of dopamine-sensitive adenylate cyclase, 
namely, the initial binding to the receptor. 
As characterized by domperidone and SCH23390 
binding studies, there are two types of dopamine binding 
sites, each of which exhibit high and low agonist affinity 
states (Hamblin et al., 1984; Hess et al., 1986). In both 
cases, the high affinity form can be converted to the low 
affinity form by the interaction with guanine nucleotides 
(Hamblin et al., 1984; Seeman et al., 1985; Hess et al., 
1986). This suggests that both the n1 and D2 receptors 
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may be linked to adenylate cyclase, D1 in a stimulatory 
capacity and D2 in an inhibitory capacity (Creese et al., 
1983). 
DOPAMINE RECEPTORS IN DEVELOPMENT AND AGING 
Much of the work done on dopamine binding during 
postnatal brain development has used [ 3H]-spiperone as 
ligand (Murrin, 1982; Nomura et al., 1982; Hartley & See-
man, 1983). Using autoradiography, following intraperit-
oneal injection of [ 3H]-spiperone, Murrin (1982) demon-
strated a dramatic increase in dopamine binding sites in 
the striatum of the rat between 5 and 15 days postnatal. 
Binding, similar to that found in the adult, was achieved 
by 15 days of age. In vitro binding studies have demon-
strated that [ 3H]-spiperone binding increases rapidly 
from day 5 (Hartley and Seeman, 1983) to a peak at 30 days 
of age (Nomura et al., 1982). Between 30 and 70 days of 
age, there is reportedly a small decrease in spiperone 
binding (Nomura et al., 1982). 
[ 3H]-Spiperone has also been used to assess 
dopamine receptors in studies of aging. In all studies, 
[ 3H]-spiperone binding was lower in the aged animals (24 
to 28 month old rats, and 5.5 year old rabbits) than in 
young animals (3 month old rats, and 5 month old rabbits) 
(Govoni et al., 1978; Govoni et al., 1980; Memo et al., 
1980; Misra et al., 1980; Thal et al., 1980; DeBlasi & 
Mennini, 1982; Trabucchi et al., 1982; Cimino et al., 1983; 
Govoni et al., 1983; Missale et al., 1983). In general, 
the Bmax was 30-50% lower in aged animals (Memo et al., 
1980; Misra et al., 1980; DeBlasi & Mennini, 1982; 
Trabucchi et al., 1982; Missale et al., 1983). 
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Because spiperone binds to both the D1 and o2 
receptors, there is little information available about 
which specific receptor subtype is primarily affected by 
aging. However, limited studies using [ 3H]-domperidone 
(Trabucchi et al., 1982; Missale et al., 1983) and [ 3H]-
sulpiride, D2 antagonists, (Memo et al., 1980; Missale et 
al., 1983) suggest that the decreased spiperone binding in 
aged animals is due to a decrease in the number of D1 
receptor sites. This decrease may be the result of either 
a decrease in the number of receptors per cell or a loss of 
neuronal synapses, or both (Severson & Finch, 1980). 
DOPAMINE RECEPTORS AND ETHANOL 
There is disagreement as to the effects of chronic 
ethanol consumption on the binding of ( 3H]-spiperone to 
dopamine receptors. Some investigators find no difference 
in Kd or Bmax between control and ethanol-treated ani-
mals (Tabakoff & Hoffman, 1979; Rabin et al., 1980). 
Others find a small decrease in the Ka for [ 3H]-spip-
erone (Barbaccia et al., 1980; Reggiani et al., 1980; 
Barbaccia et al., 1982; Lucchi et al., 1983). In summary, 
it appears that chronic ethanol consumption has little 
effect on the kinetics of binding to dopamine receptors. 
DOPAMINE-SENSITIVE ADENYLATE CYCLASE 
BIOCHEMICAL PROPERTIES 
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Adenylate cyclase is a membrane-associated enzyme 
which catalyzes the conversion of ATP to 3 1 -5 1 cyclic AMP 
(cAMP) (Spiegel et al., 1985). The cAMP produced then 
binds to the regulatory subunit of cAMP-dependent protein 
kinase, causing it to dissociate from the catalytic sub-
unit. The active catalytic subunit of protein kinase 
subsequently stimulates the phosphorylation of one or more 
cellular proteins (Figure 4). Adenylate cyclase is activ-
ated by specific hormones and neurotransmitters through a 
two-step process (Spiegel et al. 1985). The unoccupied 
receptor interacts with the guanine-nucleotide binding 
protein (G-protein) which enhances the affinity of the 
receptor for the hormone or neurotransmitter. When do-
pamine, f9r example, binds to the D1 receptor, GTP binds 
to the G-protein, which results in the activation of the 
G-protein. The activated G-protein dissociates from the 
receptor and stimulates the catalytic subunit of adenylate 
cyclase to form cAMP (Spiegel et al., 1985). The GTP is 
then hydrolyzed to GDP and Pi by the intrinsic GTPase 
activity in the G-protein, which causes the G-protein to be 
deactivated. The deactivated G-protein dissociates from 
adenylate cyclase and reassociates with the receptor to 
complete the cycle (Figure 4) (Spiegel et al., 1985). 
Dopamine-sensitive adenylate cyclase has a Km 
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Figure 4. Schematic Representation of Hormone-
and Neurotransmitter-Sensitive Adenylate 
Cyclase. 
H, R, and G, represent the hormone, receptor, and 
guanine nucleotide binding protein, respectively. 
The subscripts s and i represent stimulatory and 
inhibitory, respectively. 
(Speigel et al., 1985) 
for dopamine of 4-5 µM (Nathanson, 1977; Miller & Mc-
Dermed, 1979), with maximal stimulation above 50 µM do-
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pamine (Miller & McDermed, 1979). stimulation by dopamine 
is inhibited well by cis-flupenthixol (Enjalbert et al., 
1978: Miller & McDermed, 1979). Haloperidol is a less 
potent inhibitor of adenylate cyclase. Sulpiride, a D2 
antagonist, does not inhibit dopamine stimulation of 
adenylate cyclase (Miller & McDermed, 1979). 
DOPAMINE-SENSITIVE ADENYLATE CYCLASE DURING DEVELOPMENT AND 
AGING 
During postnatal development in the rat striatum, 
the basal (unstimulated) activity of adenylate cyclase, as 
well as the dopamine-stimulated adenylate cyclase activity, 
increased from days 1 to 23 (Enjalbert et al., 1978). Al-
though the amount of cAMP produced upon stimulation by 100 
µM dopamine increased as a function of age, the % stimula-
tion decreased from 350% on day 1 to 180% on day 23 
(Enjalbert et al., 1978), because of the age-related rise 
in the basal activity. 
During aging in rabbits (Makman et al., 1980) and 
rats (Zimmerman & Berg, 1975; Puri & Volicer, 1977; Schmidt 
& Thornberry, 1978), there was no change in the basal 
adenylate cyclase activity (Zimmerman & Berg, 1975; Puri & 
Volicer, 1977; Schmidt & Thornberry, 1978; Makman et al., 
1980) or that stimulated by NaF, which acts directly on the 
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enzyme (Zimmerman & Berg, 1975; Puri & Volicer, 1977). 
However, the stimulation of adenylate cyclase by 100 uM 
dopamine was decreased in aged (24 to 30 month old) rats 
(Puri & Volicer, 1977; Schmidt & Thornberry, 1978) and (5.5 
year old) rabbits (Makman et al., 1980) as compared to 
adult animals. This decreased stimulation was observed in 
rats at as early as 12 months of age (Puri & Volicer, 1977; 
Schmidt & Thornberry, 1978). By 30 months of age, no 
statistically significant stimulation by dopamine was 
detected (Puri & Volicer, 1977). Because there was no 
change in basal adenylate cyclase activity, the total 
amount of enzyme present was not affected by aging, sug-
gesting that the o1 receptor-containing cells were not 
lost. Therefore, the observed decrease in stimulation may 
be due to changes in membrane composition and fluidity. 
DOPAMINE-SENSITIVE ADENYLATE CYCLASE AND ETHANOL 
Ethanol, added in vitro to membrane preparations, 
increased the basal activity of adenylate cyclase (Hoffman 
et al., 1983), but had no effect on dopamine stimulation of 
adenylate cyclase activity (Hunt et al., 1979). However, 
chronic administration of ethanol produced an increase in 
the basal activity (Kuriyama et al., 1977; Lucchi et al., 
1983), with no change in that which was stimulated by NaF 
(Kuriyama et al., 1977; Tabakoff & Hoffman, 1979; Lucchi et 
al., 1983). In addition, chronic ethanol treatment pro-
duced a decrease in sensitivity to dopamine (Lucchi et al., 
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1983), which was most evident upon withdrawal (Tabakoff & 
Hoffman, 1979). When ethanol was added in physiological 
concentrations to ethanol-tolerant membranes, the dopamine 
sensitivity of the adenylate cyclase activity returns to 
normal values, suggesting that dopamine sensitive adenylate 
cyclase is adapted to physiological ethanol concentrations 
in chronic ethanol exposure. The decreased sensitivity of 
the adenylate cyclase to dopamine stimulation was due to a 
decrease in the efficiency of coupling between the dopamine 
receptor and the adenylate cyclase catalytic site (Tabakoff 
& Hoffman, 1979), which could be due, in part, to a change 
in membrane composition and fluidity. 
DOPAMINE UPTAKE 
BIOCHEMICAL PROPERTIES 
Dopamine uptake into synaptosomes is an energy de-
pendent, temperature-sensitive process. This process func-
tions to remove released dopamine from the synaptic cleft, 
and hence, to terminate the biological response (Horn, 
1979). The uptake process is dependent on sodium and to a 
lesser extent potassium. Calcium is not required. At 
37°c, the uptake is linear for 5 to 10 minutes and is 
proportional to the amount of synaptosomal protein in the 
assay mixture (Horn, 1979). Dopamine uptake is competi-
tively inhibited in vivo (Manias & Taylor, 1983) and in 
vitro (Hunt et al., 1974; Horn, 1979) by nomifensine 
(8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline) 
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which inhibits the accumulation of dopamine in synaptosomes 
without stimulating the release of dopamine (Hunt et al., 
1974; Horn, 1979; Manias & Taylor, 1983). When adminis-
tered in vivo, nomifensine produces a 3-fold increase in 
the Km for dopamine (Manias & Taylor, 1983). 
DOPAMINE UPTAKE DURING DEVELOPMENT AND AGING 
Dopamine uptake has been studied during postnatal 
development in the rat. The reuptake of dopamine in new-
born rats was 10% of that in the adult rats (Horn, 1979). 
When uptake was determined at 100 nM [ 3H]-dopamine, there 
was a 3-fold increase in uptake (pmole/g wet wt tissue) 
from day 6 to day 22 postnatal (Slotkin et al., 1980; Des-
kin et al., 1981). This increase is due to an increase in 
Vmax; the Km was unchanged (Coyle & Campachiaro, 1976). 
The changes in dopamine uptake during aging have 
been studied in C57BL/6J mice (Jonec & Finch, 1975). Up-
take into crude synaptosomes at 10 nM [ 3HJ-dopamine was 
30% lower in 28 month old mice than in mature (2-3 month 
old) mice. At 120 nM [ 3HJ-dopamine, no difference was 
observed. Kinetic analysis revealed a 35% increase in the 
Km for dopamine in old mice as compared to controls. The 
Vmax was unchanged (Jonec & Finch, 1975) . The increase 
in Km was suggested to be due to a decreased "native" 
affinity for dopamine. Alternatively, an endogenous com-
petitive inhibitor may be present in the aged mice, whose 
inhibition can be overcome at high dopamine concentrations. 
MEMBRANE COMPOSITION AND FLUIDITY IN 
NEUROTRANSMITTER SYSTEMS 
The effect of increasing membrane fluidity on 
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epinephrine- and adenosine-stimulated adenylate cyclase has 
been studied using cis-vaccenic acid as a fluidizing agent 
and fluorescence polarization with DPH to determine the 
membrane microviscosity (Rimon et al., 1978). There are 
two types of adenylate cyclase-receptor coupling mechan-
isms, a mobile receptor, and a receptor that is permanently 
coupled to adenylate cyclase. If the receptor is mobile, 
requiring lateral diffusion to activate adenylate cyclase, 
it would be expected that the activation would be increased 
with increasing fluidity (decreasing the resistance to 
lateral diffusion) . This was observed in the epinephrine-
stimulated adenylate cyclase system, known to act through a 
mobile receptor. The adenosine receptor, on the other 
hand, is believed to be permanently coupled to adenylate 
cyclase. As would be expected in this type of system, the 
activation of adenosine-sensitive adenylate cyclase was 
independent of membrane fluidity (Rimon et al., 1978). 
The influence of membrane fluidity on the binding 
of serotonin (Heron et al., 1980a,b) and opiates (Heron et 
al., l980a; Heron et al., 1981) to their receptors was 
studied. Crude synaptosomes were incubated with lecithin 
or linoleic acid, to increase fluidity, or with cholesteryl 
hemi-succinate or stearic acid, to decrease fluidity. De-
creasing membrane fluidity (increasing viscosity) produced 
a 5-fold increase in [ 3H]-serotonin binding and a 2-fold 
increase in [ 3H]-enkephalin and ( 3H]-naloxone binding. 
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As the viscosity was increased further, binding was rapidly 
lost, possibly due to increased degradation or "shedding" 
of receptors into the medium (Heron et al., 1980a,b; Heron 
et al., 1981). Fluidization of the membrane produced a de-
crease in the binding of all three ligands. The authors 
suggest that their observations with more viscous membranes 
have implications in aging and chronic drug treatment. 
Dopamine receptors have been studied as a function 
of membrane fluidity using spiperone as a ligand (Henry & 
Roth, 1986). The concentrations of spiperone used, 0.25 to 
10 nM, would characterize primarily the o2 receptor. 
Crude striatal membranes from mature (3-6 months of age) 
and aged rats (24-25 months of age) were incubated with up 
to 10% (v/v) ethanol for 15 minutes to fluidize the mem-
branes. Incubation with cholesterol hemisuccinate for 2 
hours produced an increase in membrane viscosity. Spip-
erone binding to membranes from both mature and aged ani-
mals showed an increase in the Kd for spiperone as the 
membrane was made more rigid. However, there was no dif-
ference between the response in mature and aged animals 
that were subjected to identical treatments. The Bmax 
for spiperone binding was lower in the aged animals. But 
the Bmax for membranes from both mature and aged animals 
was decreased as the membrane viscosity was artifically 
increased. Fluidizing the membrane with ethanol had no 
effect on either the Ka or Bmax for spiperone binding 
to membranes from mature or aged animals (Henry & Roth, 
1986). 
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In the above studies (Heron et al., 1980a,b; Heron 
et al., 1981; Henry & Roth, 1986), incubation times of up 
to 2 hours at room temperature were utilized to alter the 
membrane fluidity. In our hands, the incubation of mem-
branes for more than 45 minutes in buffer produced changes 
in the binding kinetics of the o1 receptor. Therefore, a 
method which utilizes shorter incubation times may be the 
method of choice for studies of this type. 
One such method was described by North and 
Fleischer (1983a,b) who altered the Chol/PL of synaptosomes 
and SPM using liposomes made of cholesterol and/or PC, and 
a non-specific lipid transfer protein (ns-LTP) from beef 
liver (Crain & Zilversmit, 1980). The altered membranes 
were studied to determine the effect of changes in membrane 
fluidity on sodium-dependent GABA uptake and GABA binding. 
This method has advantages over other, non-protein-mediated 
methods because a large change in Chol/PL can be achieved 
using short incubation times (30-60 minutes). Using the 
ns-LTP, the Chol/PL of SPM was varied from 0.21 to 1.19, 
from the normal value of 0.52. The Chol/PL of synaptosomes 
was varied from 0.16 to 0.81, from the normal value of 0.38 
(North & Fleischer, 1983a,b). It should be noted that the 
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Chol/PL of synaptosomes is lower than that of SPM. This 
difference is due to the presence of mitochondria contain-
ing little cholesterol within the synaptosomes. The in-
crease in Chol/PL, and accompanying decrease in membrane 
fluidity as determined by DPH fluorescence polarization, 
produced no changes in either GABA uptake or binding (North 
& Fleischer, 1983b). Decreasing the Chol/PL of synapto-
somes to 40% of normal produced a 70-100% loss of GABA 
uptake and a 50% decrease in the Bmax for GABA binding. 
NONSPECIFIC LIPID TRANSFER PROTEIN 
Lipid transfer proteins (LTP) are present in the 
cytosol of many tissues and vary in their specificity to-
ward the various lipid classes. In beef liver, two types 
of LTPs have been identified (Zilversmit, 1983), a PC-
specific transfer protein with a molecular weight of 28,000 
and an isoelectric point, P1 , of 5.8, and two ns-LTPs, 
CMI and CMII, both with molecular weights of 14,500 and 
P1 s of 9.55 and 9.75, respectively (Crain & Zilversmit, 
1980). The ns-LTPs accelerate the transfer of cholesterol 
and many phospholipid depending on their relative concen-
tration in the donor and acceptor membranes. These two 
proteins differ in composition by two amino acids, CMI 
containing no arginine or histidine, and CMII containing 
one each of these amino acids. CMI and CMII will transfer 
cholesterol in preference to PC, even at Chol/PL as low as 
0.2 (donor membrane) (Crain & Zilversmit, 1980). Since 
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these proteins do not transfer cholesterol esters or 
triglycerides, these lipids can be used as nontransferrable 
markers. The in vivo function of ns-LTPs is not known, 
but, based on their amino acid composition, it appears that 
CMII may be identical to a Sterol Carrier Protein (SCP2), 
which shuttles intermediates in cholesterol biosynthesis 
between the inner and outer mitochondrial membranes (Noland 
et al., 1980; Crain, 1982). 
Ns-LTP has been used to alter the Chol/PL of SPM 
and synaptosomal membranes as previously described (North & 
Fleischer, 1983a,b). This method has advantages over pre-
viously used methods which required long incubation times. 
Because a wide range of Chol/PL can be obtained using short 
incubation times, the integrity and biological activity of 
SPM and synaptosomes can be preserved. 
CHAPTER III 
MATERIALS AND METHODS 
Purification of Lipid Transfer Protein from Beef Liver 
Nonspecific Lipid Transfer Protein (ns-LTP) was 
partially purified from beef liver by a modification of the 
methods of Crain and Zilversmit (1980), and North and 
Fleischer (1983b) (Figure 5). All steps were carried out 
at 4°c. Fresh beef liver was obtained from Aurora Pack-
ing Copmany, North Aurora, Illinois. A 35% (w/v) homogen-
ate was prepared in a solution containing 0.25 M sucrose, 1 
mM EDTA, 50 rnM Tris HCl, 0.02% (w/v) sodium azide, pH 7.4 
(SET buffer), and centrifuged at 13,000 x g (9,000 rpm in 
GS3 rotor, Sorvall RC-SB centrifuge) for 30 minutes. The 
supernatant was decanted and the pH adjusted to 5.1 with 3 
N HCl. After mixing for 30 minutes, the solution was cen-
trifuged at 13,000 x g (9,000 rpm) for 20 minutes. The 
clear supernatant (5.1 Supernatant) was decanted and the pH 
returned to 7.4 with 3 N NaOH. Aliquots of 900 ml were 
stored at -20°c for up to 6 months. 
Two 900 ml aliquots of 5.1 Supernatant were 
thawed. over 1 hour, ammonium sulfate was added to 40% 
saturation (243 g/liter). After an additional hour of mix-
ing, the solution was centrifuged at 13,000 x g (9,000 rpm) 
for 30 minutes. The supernatant was decanted and addition-
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FIGURE 5 39 
PREPARATION OF LIPID TRANSFER PROTEIN 
Fresh eef liver 
35% (w/v) homogenate in SET 
buffer pH 7.4 
pellet 
(discard) 
pellet 
(discard) 
pellet 
(discard) 
supernatant 
(discard) 
cfg 9,000 rpm, 30 min 
supernatant 
adjust pH to 5.1, mix 30 min 
cfg 9,000 rpm, 20 min 
supernatant 
(5.1 Supernatant) 
adjust pH to 7.4 
(may be frozen) 
add ammonium sulfate to 
40% saturation 
mix 1 hour 
cfg 9,000 rpm, 30 min 
supernatant 
add ammonium sulfate to 
90% saturation 
mix 1 hour 
cfg 9,000 rpm, 30 min 
pellet 
suspend in 25 mM Na 2HP04 10 mM 2-mercaptoetnanol 
0.02% NaN3 , pH 8.1 
dialyze against 5 mM Na 2HP04 , 5mM 2-mercapto-
ethanol, 0.02% NaN 3 , pH 8.1 
load onto Sepharex CM-C25 column 
wash column with 2 volumes dialysis buffer 
I 
elute from column with 2 volumes 25 mM Na2HP04 , 45 mMaCl, 5 mM 2-mercaptoethanol, 0.02% NaN3 , pH 8.1 
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al ammonium sulfate was added over 1 hour to 90% satura-
tion (375 g/liter). After 1 hour of mixing, the solution 
was centrifuged at 13,000 x g (9,000 rpm) for 30 minutes. 
The supernatant was discarded, and the pellet was suspended 
in a solution containing 25 rnM sodium phosphate, 10 rnM 2-
mercaptoethanol, 0.02% (w/v) sodium azide, pH 8.1. The 
suspension was extensively dialyzed against a solution 
containing 5 rnM sodium phosphate, 5 rnM 2-mercaptoethanol, 
0.02% (w/v) sodium azide, pH 8.1 (dialysis buffer), using 
Spectra/Per 1 (Spectrum Medical Industries, Inc., Los 
Angeles) dialysis tubing with a molecular weight cutoff of 
6000-8000 daltons. 
The dialysate was applied, at a flow rate of 1 
ml/min, to a 5 x 60 cm Sephadex CM-C25 (Pharmacia, Inc., 
Uppsala, Sweden) ion exchange column, which had been pre-
equilibrated with dialysis buffer. The column was washed 
with 2 column volumes of dialysis buffer, and eluted, at a 
flow rate of 2 ml/min, with 2 column volumes of a solution 
containing 25 rnM sodium phosphate, 45 rnM NaCl, 5 rnM 2-mer-
captoethanol, 0.02% (w/v) sodium azide, pH 8.1 (elution 
buffer) . LTP was eluted following a large peak of yellow 
material. Transfer activity was stable for up to 1 month 
when stored at 4°C in elution buffer. Prior to use in 
lipid transfer experiments, the eluate was concentrated 5-
to 10- fold by ultrafiltration through an Amicon stirred 
ultrafiltration cell, equipped with a Diaflo YM5 membrane, 
with a molecular weight cutoff of 5000 daltons (Amicon 
Corp., Danvers, MA). 
SOS-PAGE 
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To qualitatively determine the purity of the 
transfer protein preparations, aliquots of fractions from 
the different purification steps were separated by sodium 
dodecyl sulfate (SOS) polyacrylamide gel electrophoresis 
(PAGE) . Samples were prepared in a solubilizing solution 
and boiled for 2 minutes at ioo0 c. The solubilizing 
solution was prepared from 1 ml of 10% (w/v) sos, 150 mg 
dithiothreitol, and 800 mg sucrose in 10 ml of deionized 
water. Bromothymol blue was added and the samples were 
centrifuged before application to the gel. 
Slab Gel Preparation. Because the expected molec-
ular weight of the transfer protein was approximately 14K, 
gels of 12.5% (w/v) acrylamide were prepared to assure a 
good separation in the low molecular weight region. Gels 
of 3 mm thickness were prepared with 41.7 ml Solution A 
(below), 12.5 ml Solution B, 1 ml of Solution c, 44.65 ml 
deionized water, 0.15 ml TEMEO (diluted 1:10 with deionized 
water), and 100 mg ammonium persulfate. After pouring, the 
gels were overlayed with isobutanol and allowed to polymer-
ize. After polymerization, the gels were rinsed with de-
ionized water and blotted. Spacer gels of 3% (w/v) acryl-
amide were prepared with l ml Solution A, 1.25 ml Solution 
D, O.l ml Solution c, 8.15 ml deionized water, 0.05 ml 
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TEMED (diluted 1:10 with deionized water) and 10 mg ammon-
ium persulfate, and poured within a few mm of the top of 
the comb used to form the sample wells. Solution A con-
tained 30% (w/v) acrylamide and 0.8% (w/v) Bis. Solution B 
contained 36.6% (w/v) Tris base, pH 8.9. Solution c con-
tained 10% (w/v) SDS. Solution D contained 5.89% (w/v) 
Tris base, pH 6.7. 
Samples were applied and overlayed with running 
buffer. The running buffer contained 0.02% (w/v) SDS, 1.4% 
(w/v) glycine, 0.3% (w/v) Tris pH 8.4. Low molecular 
weight standards (Bio-Rad), including lysozyme (14.4K), 
soybean trypsin inhibitor (21.SK), carbonic anhydrase 
(31K), ovalbumin (45K), bovine serum albumin (66.2K), and 
phosphorylase B (92.SK), were run with samples in each 
gel. Current was applied at 10 amps per gel until the 
samples reached the stacking gel. Thereafter, the current 
was maintained at 20 amps per gel. Gels were run until the 
tracking dye reached the end of the gel. Gels were fixed 
and stained in a solution containing 0.1% (w/v) Coomassie 
Blue, 50% (v/v) methanol, and 10% (v/v) acetic acid, fol-
lowed by destaining in a solution containing 7.5% (v/v) 
acetic acid and 7.5% (v/v) methanol. 
PREPARATION OF MITOCHONDRIA FOR CHOLESTEROL TRANSFER ASSAY 
Mitochondria were prepared using an adaptation of 
the method of Cotman and Matthews (1971). A 10% (w/v) hom-
ogenate of beef heart was prepared in 0.32 M sucrose, 5 mM 
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Tris base, pH 7.0 (sucrose buffer) using a Tekmar tissu-
mizer (Tekmar, Cincinnati, OH). The homogenate was centri-
fuged at 1,100 x g (3,000 rpm in an SS34 rotor) for 5 
minutes. The supernatant was decanted into clean centri-
fuge tubes and centrifuged at 17,000 x g (13,700 rpm) for 
10 minutes. The pellet was suspended in 15 ml of sucrose 
buffer and layered onto 15 ml of 38% (w/v) sucrose, fol-
lowed by centrifugation at 106,000 x g (24,250 rpm in SW-28 
rotor) for 2 hours. The pellet was resuspended in sucrose 
buffer and stored at -8o0 c. Prior to use in the choles-
terol transfer assay, mitochondria were heated to 8o0 c 
for 20 minutes to inactivate endogenous lipases. Heat-
treated mitochondria were subsequently washed with 50 mM 
Tris HCl, pH 7.4. 
PREPARATION OF LIPOSOMES 
Liposomes that would be used in an assay of cho-
lesterol transfer activity were prepared with 1 mg egg PC 
per ml, 1 mole of cholesterol per mole of PC, with 0.25 µCi 
each of [ 3H]-triolein and [ 14c]-cholesterol per ml of 
liposomes added as nontransferrable and transferrable mark-
ers, respectively (North & Fleischer, 1983b). Liposomes, 
for depletion of cholesterol from synaptosomes or SPM, were 
prepared using 10 mg of egg phosphatidylcholine (PC) per 
ml. Those to be used to increase the Chol/PL of synapto-
somes and SPM were prepared with 5 mg PC per ml with 1.7 
moles of cholesterol per mole of PC (4.4 mg cholesterol per 
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ml). [ 14c]-Tripalmitin (0.25 µCi/ml) was included in all 
liposomes as a nontransferrable marker (North & Fleischer, 
1983b). To prepare liposomes, the lipids were mixed in 
chloroform and dried under nitrogen to a thin film which 
coated the walls of an acid-washed tube. The lipid layer 
was dispersed in 50 mM Tris HCl, pH 7.4 (for the liposomes 
to be used for the cholesterol transfer assay) or 0.32 M 
sucrose, 5 mM Tris base, pH 7.0 (for the liposomes to be 
used for cholesterol loading and depletion) by extensive 
mixing using a vortex mixer, followed by sonication until 
the lipid mixture was transleucent, using a Cole Palmer 
Ultrasonic Homogenizer 4710 (Cole Palmer Instrument Co., 
Chicago, IL), equipped with a 1/2 inch tipped horn, at 80% 
duty cycle. After sonication, the liposomes were centri-
fuged at 27,000 x g (15,000 rpm, SS34 rotor) for 60 minutes 
at 25°c to remove titanium fragments from the sonicator 
tip and undispersed lipid. Liposomes were generally used 
within 3 hours of preparation. 
CHARACTERIZATION OF LIPOSOMES 
In order to correct for the sticking of liposomes 
to the synaptosomes and SPM in the calculation of the Chol/ 
PL, it is necessary to establish that the phospholipid, 
cholesterol, and nontransferrable marker are uniformly dis-
tributed throughout the population of each type of liposome 
used. To accomplish this, the liposomes were chromato-
graphed on a Sepharose 4B-CL column (Wong et al., 1982), 
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with 50 mM Tris HCl, pH 7.4 as the running buffer. Before 
applying the liposomes to be separated, the column was sat-
urated with unlabelled liposomes, to occupy the hydrophobic 
binding sites, and washed extensively. Fractions of 1 ml 
were collected and assayed for phosphorus and cholesterol. 
The radioactivity in each fraction was determined by liquid 
scintillation counting. 
ASSAY OF CHOLESTEROL TRANSFER ACTIVITY 
Cholesterol transfer activity was assayed by 
incubating purified transfer protein (up to 100 µl) with 
800 ul of liposomes and 100 ul of heat-treated mitochondria 
at 32°c for varying times. Blanks (without transfer 
protein) were included for each time point. The reaction 
was terminated by vacuum filtration through Whatman GF/C 
filters, which had been preincubated with unlabelled 
liposomes, followed by 3 washes with 5 ml of 50 mM Tris 
HCl, pH 7.4 (North & Fleischer, 1983b). Filters were 
placed in 10 ml of Ecoscint and the radioactivity deter-
mined in a Beckman LS-7500 liquid scintillation counter 
with data reduction. 
The purpose of the assay was to demonstrate a 
unidirectional transfer of cholesterol from a donor lipo-
some into mitochondria. The mitochondrial membrane is a 
good acceptor because it contains very little cholesterol. 
The liposomes used in the assay contained [ 14c)-Choles-
terol and [ 3H]-Triolein as transferrable and nontrans-
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ferrable markers, respectively. After the incubation, the 
mitochondria will have a 14c; 3H that is greater than 
the 14c; 3H of the liposomes, it a net transfer has 
taken plase. The net transfer was calculated as follows: 
1 4c due to = (3H in sample)x( 14c; 3H in liposomes) 
sticking 
net 14c = 14c in sample - 14c due to sticking 
nmol chol = net 14c x nmole ihol in liposomes 
transferred 1 C in liposomes 
PREPARATION ON SYNAPTOSOMES AND SYNAPTIC PLASMA MEMBRANES 
Synaptosomes and synaptic plasma membranes (SPM) 
were prepared from whole rat brain by the method of Cotman 
and Matthews (1971) (Figure 6). All steps were carried out 
at 4°c. 
Male Sprague-Dawley rats (Holtzman, Madison, WI), 
40 +/- 5 days old were housed 3 to a cage with a 12 hour 
light dark cycle. Animals were sacrificed between 7 a.m. 
and 8 a.m. by decapitation. The brains were removed and 
placed in ice cold 0.32 M sucrose, 5 mM Tris base, pH 7.0 
(sucrose buffer). A 10% (w/v) homogenate was prepared 
using a glass homogenizer with a teflon pestle. The tissue 
was homogenized at 1000 rpm, with 4 up and down strokes. 
The homogenate was centrifuged at 1100 x g (3,000 rpm in 
SS34 rotor, Sorvall RC-5B centrifuge) for 5 minutes. The 
supernatant was decanted into clean centrifuge tubes and 
pelleted at 17,000 x g (13,700 rpm) for 10 minutes. The 
pellet was resuspended in 15 ml of sucrose buff er using a 
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RAT SYNAPTOSOMES AND SYNAPTIC PLASMA MEMBRANES 
Fresh rat whole brain 
I 
10% 
~, --------~--1- cfg 
(w/v) homogenate in 
sucrose buff er 
3,000 rpm, 5 min 
P1 S1 
( dis.-c_a_r_d_) --------11 cfg 
I 13,700 rpm, 10 min 
S2 P2 (discard) 
. 3 (discard) 
suspend in 15 ml sucrose 
buff er (hand-held 
homogenizer) 
cfg 11,000 rpm, 20 min 
layer onto Ficoll gradient 
(13.0%/7.5%) 
cfg 22,000 rpm (SW 28 rotor) 
45 min 
Synaptosomes found at 7.5%/13.0% Ficoll interface. Remove 
· interface and dilute w/ 
4 vol sucrose buff er 
cfg 24,250 rpm, 30 min 
pellet (synaptosomes) 
osmotically shock in 6 mM 
Tris, pH 8.1, 90 min 
cfg 20,300 rpm, 15 min 
pellet 
suspend in 5 ml sucrose 
buff er 
layer onto sucrose gradj.ent 
(38%/35%/32.5%/25%/10%) 
cfg 24,250 rpm, 90 min 
SPM found at 25%/32.5% sucrose interface. 
Remove interface and dilute w/4 vol 
sucrose buff er 
cfg 24,250 rpm, 30 min 
pellet (SPM) - suspend in sucrose buffer - store -00°c 
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round bottom, hand-held glass homogenizer, prior to 
centrifugation at 11,000 x g (11,000 rpm} for 20 minutes. 
The pellet was suspended in 5 ml of sucrose buffer and 
layered onto a discontinuous Ficoll-sucrose gradient 
consisting of 13 ml of 13.0% (w/v) Ficoll 400 in sucrose 
buffer and 13 ml of 7.5% (w/v) Ficoll 400 in sucrose 
buffer. Following centrifugation at 63,581 x g (22,000 rpm 
in SW-28 rotor, Beckman L5-65 ultra-centrifuge) for 45 min-
utes, the synaptosomal material, found at the 7.5%/13.0% 
Ficoll interface, was removed, diluted with 4 volumes of 
sucrose buffer, prior to centrifugation at 106,000 x g 
(24,250 rpm) for 30 minutes. The pellet contained synap-
tosomes which were used directly for cholesterol transfer 
and dopamine uptake assays. 
To prepare SPM for membrane fluidity studies, the 
synaptosomal pellet was suspended in a small volume of su-
crose buffer, osmotically shocked with 6 volumes of 6 mM 
Tris base, pH 8.1 for 90 minutes, and centrifuged at 54,500 
x g (20,300 rpm) for 15 minutes. The resulting pellet was 
resuspended in 5 ml of sucrose buff er and layered onto a 
discontinuous sucrose gradient which consisted of the fol-
lowing concentrations of sucrose solutions with 5 mM Tris 
base, pH 7. O, in ascending order: 38. 0% (w/v) ( 5 ml) , 
35.0% (w/v) (5 ml), 32.5% (w/v) (5 ml), and 25.0% (w/v) (10 
ml). The gradient was centrifuged at 106,000 x g (24,250 
rpm) for 90 minutes. SPM, found at the 32.5%/25.0% inter-
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face, were removed, diluted with 4 volumes of sucrose buf-
fer, and pelleted at 106,000 x g (24,250 rpm) for 30 min-
utes. The pellet was suspended in a small volume of su-
crose buffer and stored at -so0 c. 
Bovine brain was obtained as a generous gift from 
Aurora Packing Company, North Aurora, Illinois. Fresh 
brains were kept ice-cold in 50 mM Tris HCl, pH 7.4, during 
transportation. The caudate was removed (Yoshikawa, 1968), 
and homogenized in sucrose buff er as described for rat 
brain. Because the bovine myelin and synaptosomal frac-
tions were found to have a lower density than those from 
rat brain, it was necessary to make two modifications of 
the Cotman and Matthews (1971) method. 1) In the prepara-
tion of synaptosomes, the Ficoll-sucrose gradient consisted 
of 13 ml of 14.0% (w/v) Ficoll and 13 ml of 6.0% (w/v) Fi-
coll. 2) In the isolation of SPM from synaptosomes, the 
25% (w/v) sucrose solution from the sucrose gradient was 
replaced by 20.0% {w/v) sucrose (Figure 7). Bovine synap-
tosomes were used directly for cholesterol transfer and 
o1 binding and adenylate cyclase assays. SPM were stored 
at -so0 c. 
MARKER ENZYME ASSAYS 
The relative purity of SPM and synaptosomes pre-
pared from rat whole brain and bovine caudate was assessed 
by determining the activities of enzymatic markers. 
Mg2+-dependent, ouabain-sensitive (Na+-K+)-ATPase {EC 
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cfg 24,240 rpm, 30 min 
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buff er 
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cfg 24,250 rpm, 90 min 
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. 
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pellet (SPM) - suspend in sucrose buffer - store -8o0 c 
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3.6.1.4) (Sweadner, 1978) is found enriched in plasma mem-
branes. Acid phosphatase (EC 3.1.3.2) (Linhardt & Walter, 
1963), cytochrome c oxidase (EC 1.9.3.1) (Duncan & Mackler, 
1966), and 2',3'-cyclic nucleotide 3'-phosphohydrolase, 
CNPase (EC 3.1.4.16) (Kurihara & Tsukada, 1967) are 
enzymatic markers for lysosomal, inner mitochondrial, and 
myelin membranes respectively. 
Na+-K+ ATPase. Na+K+-dependent, Mg 2+-
stimulated, ouabain-sensitive ATPase is a marker for plasma 
membranes. Enzyme activity was assayed by a modification 
of the method of Abdel-Latif et al. (1970). All samples 
were preincubated for 2 minutes at room temperature in 
0.02% (w/v) SDS. Rat whole brain and bovine caudate hom-
ogenates (90-100 ug protein), synaptosomes (50-80 ug pro-
tein), or SPM (30-50 ug protein) were incubated in 450 µl 
of reaction mixture for 10 minutes at 37°c before initi-
ating the reaction with 50 µl of ATP (18 mg ATP per ml -
final concentration 3 mM ATP). The final assay buffer con-
tained: 150 mM NaCl, 20 mM KCl, 3 mM MgC1 2 , 40 mM Tris 
base, and 3 mM ATP, pH 7.4. Ouabain sensitivity was deter-
mined in the presence of 10 mM ouabain. After 10 minutes, 
the reaction was terminated by the addition of 150 µl of 
ice cold 50% (w/v) trichloroacetic acid, and placing the 
tubes in an ice bath. After centrifugation at low speed, a 
500 µl aliquot of the supernatant was removed for quanti-
tation of the inorganic phosphate released in the reaction, 
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using this laboratory's modification of the Fiske Subbarow 
phosphorus assay (Fiske & Subbarow, 1925) (assay described 
on page 63). 
CNPase. CNPase, a marker for myelin, was assayed 
by the method of Kurihara and Tsukada (1967). Tissue sam-
ples were prepared in 1% (v/v) Triton X-100 to give a con-
centration of 0.25 µg protein/µl. The reaction tubes, con-
taining 50 µl of 0.03 M 2',3'-cAMP, 50 ul of a solution 
containing 0.2 M Na 2HP04 and 0.1 M citrate pH 6.2, and 
80 µl deionized water, were preincubated for 5 minutes at 
37°C. The reaction was initiated by the addition of 20 
µl of tissue in Triton x-100. Tubes without tissue were 
also included as substrate blanks. After 20 minutes, the 
reaction was terminated by the addition of 20 µl of glacial 
acetic acid and the tubes were placed on ice. After cen-
trifugation at low speed, a 20 µl aliquot of the superna-
tant was removed for separation on Whatman chromatography 
paper, using isopropanol:ammonia:water, 7:1:2 (v/v/v) 
(Banik and Davison, 1969) as the solvent system. The paper 
was dried in air and the nucleotide spots were visualized 
under ultraviolet light and marked. Spots corresponding to 
substrate, product, and paper blank were cut into small 
pieces and placed in test tubes. Four ml of 0.01 N HCl was 
added to each tube prior to shaking for at least 2 hours at 
room temperature. The paper was removed by low speed cen-
trifugation and the optical density (O.D.) of the superna-
tant was determined at 260 nm. Calculations were as 
follows: 
S1 = Asubstrate standard - Apaper blank 
P1 = Aproduct - Apaper blank 
x = s1/l.5 = Absorbance/µmole/assay 
y = 3(P1/X) = µmole/20 µl of assay/hour 
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z = Y/mg protein in 20 µl = µmole/hour/mg protein 
Acid Phosphatase. Acid phosphatase, a marker for 
lysosomes, was assayed by the method of Linhardt and Walter 
(1963). The assay buffer (500 ul) containing 50 mM cit-
rate, 5.5 mM p-nitrophenyl phosphate pH 4.8, was preincu-
bated for 5 minutes at 37°c. The reaction was initiated 
by the addition of 50 µl of homogenate (100-500 µg pro-
tein), synaptosome or SPM (50 µg protein), and allowed to 
proceed for 30 minutes at 37°c. Blanks, without tissue, 
and standards containing 2.5-10 x 10-5 moles of p-nitro-
phenol were included. The reaction was terminated by the 
addition of 2 ml of 0.1 N NaOH. The o.o. of blanks, stand-
ards, and samples was determined at 405 nm. Calculations 
were as follows: 
(A405 ) (2.81)/(.5) (mg protein) = mmole acid 
phosphatase units (mmole/hr/mg protein) 
Cyctochrome c Oxidase. Cyctochrome c oxidase, a 
marker for mitochondria, was assayed by the method of 
Duncan and Mackler (1966). The assay measures the rate of 
the decrease in absorbance at 550 nm due to the cytochrome 
c oxidase-catalyzed conversion of f errocytochrome c 
(Fe2+) to ferricytochrome c (Fe3+). Ferrocytochrome c 
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was prepared by the addition of sodium dithionite to ferri-
cytochrome c. Excess dithionite was removed by aeration. 
To the assay buffer, containing 0.2 ml of 0.2 M phosphate 
buffer, pH 7.5, 0.1 ml of 1% (w/v) ferrocytochrome c, and 
0.7 ml deionized water, tissue was added to give an absor-
bance change that was linear for 2-5 minutes. The enzyme 
activity was calculated from the slope of the linear de-
crease in absorbance as a function of time as follows: 
(change in A550/min)/(total absorbance change/µmole 
cytochrome c) (mg protein) = µmole/min/mg protein. 
CHOLESTEROL TRANSFER 
Synaptosomes for the o1 binding and adenylate 
cyclase assays and SPM for fluidity studies (1 mg of pro-
tein in 50 µl of 0.32 M sucrose) were preincubated for 10 
minutes at 32°c with 200 ul of concentrated transfer pro-
tein in elution buffer, 80 µl of 1.8 M sucrose, and 170 µl 
of deionized water to give a final sucrose concentration of 
0.32 M. The extent of cholesterol transfer was controlled 
by the amount of transfer protein added. The reaction was 
initiated by the addition of 500 µl of liposomes and 
allowed to continue for 30 minutes (synaptosomes) or 60 
minutes (SPM) with gentle shaking. The shorter incubation 
time was used for the synaptosomes because the viability of 
the synaptosomes was compromised, and the kinetics of 
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dopamine binding was altered with longer incubation times. 
The transfer was terminated by centrifugation through a 
layer of 0.5 M sucrose at 106,000 x g (24,250 rpm in SW-28 
rotor) for 40 minutes (North and Fleischer, 1983b). 
Several modifications were made in the cholesterol 
transfer procedure for the synaptosomes used for the do-
pamine uptake studies (North & Fleischer, 1983b). 1) So-
dium azide, which inhibits uptake processes, was removed 
prior to use in the cholesterol transfer from the transfer 
protein solution by dialysis against elution buffer without 
sodium azide. 2) In addition, 15% (v/v) Krebs-Henseleit 
buffer (see below) was included in the incubation medium to 
preserve synaptosome viability without inhibiting the 
transfer activity. 3) The reaction was terminated by 
centrifugation at 63,581 x g (22,000 rpm in SW-28 rotor) 
through 0.5 M sucrose containing 40% (v/v) Krebs-Henseleit 
buffer. 
After cholesterol transfer, the surface of each 
pellet was rinsed to remove any sedimented lipid. The 
pellet was then suspended in the assay buffer. Binding, 
uptake, and adenylate cyclase assays were performed imme-
diately after the cholesterol transfer. 
FLUORESCENCE POLARIZATION DETERMINATION OF MEMBRANE 
FLUIDITY 
The fluidity of SPM from rat whole brain and bo-
vine caudate was determined using fluorescence polarization 
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techniques. The surface and the hydrophobic core of the 
membrane were probed using l-anilinonaphthalene-8-sulfonic 
acid (ANS) and l,6-diphenyl-1,3,5-hexatriene (DPH), respec-
tively. The SPM fraction was used rather than the more 
crude synaptosomal fraction because the hydrophobic fluo-
rescent probes will partition into all cellular membranes. 
A semi-crude fraction contains mitochondria, which are low 
in cholesterol content and thereby very fluid, and myelin, 
which is high in cholesterol content and, hence, very rig-
id. Fluorescence polarization analysis of such mixed 
membrane fractions could confound the interpretation of the 
data. 
For the DPH studies, SPM (50 ug of SPM protein) 
were incubated with 1 µM DPH in phosphate buffered saline 
(PBS), pH 7.4 (136.9 mM NaCl, 2.68 mM KCl, 8.1 mM 
Na 2HP04 , 1.47 mM KH2Po4 ) at 37°c for 30 minutes to allow 
the probe to equilibrate into the membrane. SPM for the 
ANS study were incubated at room temperature for 15 minutes 
with 200 µMANS in PBS containing 10 mM Mgso4 . The di-
valent magnesium cation was used to neutralize surface 
negative charges and to allow the ANS to interact more 
efficiently with the membrane, and hence to enhance the 
fluorescence signal. 
The fluorescence of the SPM was determined in a 
Perkin Elmer MPF-44B Fluorescence Spectrophotometer, 
equipped with rotating polarizing filters. For the DPH 
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studies, an excitation wavelength of 360 (slit width 3 nm) 
and emission wavelength of 430 nm (slit width 20 nm) were 
used (Shinitzky & Barenholz, 197S). For the ANS studies, 
an excitation wavelength of 395 (slit width 5 nm) and emis-
sion wavelength of 490 nm (slit width 20 nm) were used 
(Slavik, 19S2). The fluorescence of the prepared samples 
was determined at different orientations of the polarizing 
filters. 
DOPAMINE UPTAKE ASSAY 
The uptake of dopamine into control and lipid-
modified synaptosomes was assayed by a modification of the 
method of Deskin et al. (19Sl). After lipid transfer, 
synaptosomes were gently suspended in modified Krebs-
Henselei t buffer (llS mM NaCl, 26 mM Na 2HP04 , 6 mM 
NaH2Po4 , 4.7 mM KCl, 1.S mM CaC1 2 , 1.2 mM MgS04 , 1.3 mM 
EDTA, 5.6 mM D-glucose, 2 µM ascorbic acid, 10 µM 
pargyline, pH 7.4) for assay. Triplicate 100 µl aliquots 
of prepared synaptosomes, containing 200-300 µg of 
synaptosomal protein, were added to 900 µl of Krebs buffer, 
containing 10-15 nM of [ 3HJ-dopamine and 0-5,000 nM of 
unlabelled dopamine (Figure Sa). Nonspecific uptake was 
determined in the presence of 10 µM nomifensine (Figure Sb) 
(Hunt et al., 1974). All samples were incubated for 5 
minutes at 37°c with gentle shaking. The reaction was 
terminated by transferring the tubes to ice and adding 2 ml 
of ice cold Krebs buffer. All samples were vacuum filtered 
Figure 8 58 
a) Structure of Dopamine b) Structure of Nomifensine 
Cl 
HO 
c) Structure of SCH23390 d) Structure of Butaclamol 
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through Whatman GF/F filters and washed twice with 3 ml of 
Krebs buffer. Radioactivity associated with the filters 
was determined as described previously. The kinetic 
parameters ~ and Vmax were calculated for each assay 
by Hanes plot analysis. The Hanes plot is a linear 
transformation of the data which plots s/v (the substrate 
concentration/the observed rate) on the Y-axis and s (the 
substrate concentration) on the X-axis. From this plot, 
the ~ is the negative X- intercept, and the Vmax is 
l/slope. 
DOPAMINE CD1 ) BINDING ASSAY 
The dopamine o1 binding sites in control and 
lipid-modified membranes were assayed using the method of 
Hess et al. (1986) with SCH23390 (Figure Sc) as a ligand. 
After cholesterol transfer, synaptosomes were suspended in 
50 mM Tris pH 7.4 containing 5 mM Mgso4 . Membranes were 
incubated at 37°c for 15 minutes, followed by centri-
fugation at 20,000 x g for 20 minutes, to remove endogenous 
dopamine. The pellets were suspended in a solution con-
taining 50 mM Tris, 5 mM Mgso4 , 0.5 mM EDTA, and 0.02% 
(w/v) ascorbic acid, pH 7.4 (assay buffer). Duplicate 100 
µl aliquots of synaptosomes, containing 300-500 pg of 
synaptosomal protein were added to 2.9 ml of assay buffer 
containing 0.2-0.5 nM of ( 3H]-SCH23390, and 0-5.1 nM of 
unlabelled SCH23390. Samples were incubated at 37°c for 
30 minutes with gentle shaking. Nonspecific binding was 
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determined in the presence of 1 µM (+)-butaclamol (Figure 
8d) (Seeman et al., 1985). The reaction was terminated by 
vacuum filtration through Whatman GF/C filters, followed by 
three washes with 5 ml of 50 mM Tris, pH 7.4. The radio-
activity associated with the filters was determined as 
described previously. The kinetic parameters, Ka and 
Bmax' were calculated for each assay by Scatchard 
analysis. The Scatchard plot is a linear transformation of 
the experimental data in which the ratio of the concentra-
tions of bound ligand and free ligand is plotted on the 
Y-axis and the concentration of bound ligand is plotted on 
the X- axis. From the Scatchard plot, the Bmax is the 
X-intercept, and the Ka is -1/slope. 
DOPAMINE-SENSITIVE ADENYLATE CYCLASE ASSAY 
Basal and dopamine-sensitive adenlyate cyclase 
activity was assayed using control and lipid-modified bo-
vine caudate synaptosomal membranes by a modification of 
the methods of Enjalbert et al. (1978), Makman et al. 
(1980), and Waldman et al. (1985). Synaptosomes from the 
dopamine o1 binding assays were used directly for the 
adenylate cyclase assays. Synaptosomes (50 µg of protein) 
were preincubated at 3o0 c in a solution containing 80 mM 
Tris-maleate, 2 mM Mgso4 , 2 mM isobutylmethylxanthine, 
0.2 mM EGTA, 20 mM creatine phosphate, 0.2 mg/ml creatine 
kinase, and 50 µM GTP, pH 7.4, in the presence or absence 
of 100 µM dopamine. The reaction was initiated by the 
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addition of 0.5 mM ATP and allowed to proceed for 5 min-
utes. The reaction was terminated by the addition of 50 mM 
sodium acetate pH 4.0 and immersion in a boiling water bath 
for 3 minutes. Precipitated protein was removed by centri-
fugation at 23,000 x g (15,000 rpm in SE12 rotor) for 15 
minutes. The supernatants were stored at -ao0 c until 
cyclic AMP radioimmunoassays were performed. 
CYCLIC AMP RADIOIMMUNOASSAY 
The cAMP radioimmunoassay was a modification of 
the method of Steiner (1972a,b). Before the RIA was run, 
all samples and standards were acetylated to more closely 
duplicate the antigen used to generate the antibody. This 
acetylation step greatly increases the sensitivity of the 
assay. To acetylate samples, 20 µl of triethylamine and 10 
µl of acetic anhydride were added to 500 ul of standards 
and samples. Duplicate 100 µl aliquots of standards 
(containing O to 500 fmole of cAMP) and samples were 
transferred to 12 x 75 mm tubes, and 100 µl of [ 125IJ-
cAMP, in 50 mM sodium acetate, pH 6.2, was added. To start 
the assay, 100 µl of anti-cAMP antibody (primary antiserum 
to cAMP) in acetate buffer was added, and the tubes were 
incubated in the refrigerator for 12 hours. The assay was 
stopped by the addition of 50 µl of 1% gamma globulin in 
acetate buffer and 2 ml of ice-cold 95% isopropanol. The 
tubes were centrifuged, in a Jouan GR4.11 centrifuge, at 
1,623 x g (2800 rpm) for 30 minutes at 4°c and the super-
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natant was decanted. The radioactivity associated with the 
pellets was determined in a gamma counter. 
PROTEIN DETERMINATION 
Protein was assayed following the method of Lowry 
et al. (1951). Human serum albumin (HSA), prepared at a 
concentration of 1 mg/ml in deionized water, was used as a 
protein standard. The standard curve consisted of 0-50 µg 
of protein. Standards and samples were incubated in 0.1 ml 
of 1 N NaOH for 30 minutes at room temperature to solubil-
ize membrane-bound proteins. To each tube was added 1 ml 
of a solution freshly prepared with 10 ml of 2% (w/v) so-
dium carbonate, 0.1 ml of 1% (w/v) cupric sulfate, and 0.1 
ml of 2% (w/v) K+-Na+ tartrate. After 10 minutes, 0.1 
ml of 1 N Folin phenol reagent was added. After 30 min-
utes, the O.D. of standards and samples was determined at 
700 nm. 
CHOLESTEROL ASSAY 
Cholesterol was assayed using a diagnostic kit 
(Sigma Kit 351). The assay, which quantitates both cho-
lesterol esters and cholesterol, combines cholesterol 
esterase, cholesterol oxidase, and peroxidase in a colori-
metric reaction. Cholesterol esters are hydrolyzed to free 
cholesterol and fatty acids by cholesterol esterase. The 
cholesterol is then oxidized to cholest-4-en-3-one and 
hydrogen peroxide by cholesterol oxidase. The hydrogen 
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peroxide reacts with 4-amino-antipyrine and phenol in the 
presence of peroxidase to form a quinoneimine dye which has 
an absorbance maximum at 500 nm. The reagent contains a 
detergent (sodium chelate) to free membrane bound choles-
terol and gives a linear response up to 60 ug of choles-
terol. Blanks, aqueous cholesterol standards, and tissue 
samples (containing up to 60 µg of cholesterol) were incu-
bated with 1 ml of reagent at 37°c for 10 minutes. The 
o.D. of samples and standards was determined at 500 nm 
against the blank. Because turbidity in the samples can 
lead to overestimation of the cholesterol content, the O.D. 
of each sample and standard was determined after the addi-
tion of 2 drops of 0.5 M ascorbate, which will decolorize 
the reaction mixture. The net absorbance was used to cal-
culate the cholesterol content. 
PHOSPHORUS ASSAY 
Phospholipid and inorganic phosphate was deter-
mined by a modification of the method of Fiske and 
Subbarrow (1925). Before determining the phosphorus 
concentration of SPM and synaptosomes, the tissue samples 
were extracted three times with chloroform:methanol (2:1) 
(Folch et al., 1957). The chloroform layers were combined 
and dried under nitrogen. To each residue was then added 
0.1 ml of 70% perchloric acid. Each tube was digested at 
17o0 c until no yellow color remained. After cooling, 1 
ml of deionized water was added. A standard solution of 
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o.04 mg/ml of KH2Po4 was prepared. To standards of o 
to 40 µg of phosphorus in 1 ml of deionized water, 0.1 ml 
of 70% perchloric acid was added. To each standard and 
sample, 0.25 ml of 2.5% ammonium molybdate, 0.1 ml of 
reducer, and deionized water, up to a total volume of 2.5 
ml, were added. After 10 minutes at room temperature, the 
o.D. of the standards and samples was determined at 625 
nm. The reducer was prepared by dissolving 3 g of 
Na 2so3 , 60 g of NaHso3 ,and 1 g of 1-amino-2-naph-
thalene-4-sulfonic acid in 500 ml of deionized water. 
CALCULATION OF CHOL/PL 
In order to determine an accurate Chol/PL for the 
lipid-modified SPM and synaptosomes, it was necessary to 
correct the cholesterol and phospholipid phosphorus concen-
trations for the sticking of liposomes. This was made 
possible by the inclusion of [ 14c]-tripalmitin in the 
liposomes as a nontransferrable marker. The radioactivity 
in the liposomes and tissue samples was determined by liq-
uid scintillation counting. The corrected Chol/PL was cal-
culated as follows: 
nmole chol due = (14 c in sample) x (nmole chol/ 14c) 
to sticking in liposomes 
nmole PL due 
to sticking 
= c14c in sample) x (nmol PL/14c) 
in liposomes 
net chol = (total chol - chol due to sticking)/mg protein 
net PL = (total PL - PL due to sticking)/mg protein 
corrected Chol/PL = net chol/net PL 
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DATA ANALYSIS 
Mean values reported for the marker enzyme activ-
ities, adenylate cyclase activities, and Chol/PL of control 
membranes represent the mean +/- the standard deviation of 
several samples, where n = the number of determinations. 
student's 't' test for significance was used when comparing 
the marker enzyme activities of synaptosomes and SPM to 
homogenates. P values of <0.05 were considered to repre-
sent significant differences. 
Data from the dopamine uptake studies was analyzed 
by Hanes plot analysis of triplicate determinations. The 
Km and Vmax values for each assay were calculated from 
the X-intercept and the slope, respectively. Only assays 
with as least 5 data points and a correlation coefficient 
of 0.9 or better for the linear fit of the Hanes plot were 
included. 
Data from the SCH23390 binding studies was anal-
yzed by Scatchard analysis of duplicate determinations. 
The Ka and Bmax were calculated from the slope and 
X-intercept, respectively. The criteria for inclusion of 
assays was identical to that used for the dopamine uptake 
studies. 
Linear analysis of standard curves, Hanes and 
Scatchard plots was by the method of least squares. Unless 
otherwise noted, the lines describing the relationship be-
tween the Chol/PL and the various parameters studied were 
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estimated from the data to show a general trend, and were 
not calculated from theoretical equations relating Chol/PL 
to the experimental parameters. 
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CHEMICALS 
chemical Source 
sucrose J.T. Baker, Phillipsburg, NJ 
EDTA Sigma, St. Louis, MO 
Trizma HCl Sigma 
Trizma OH Sigma 
Sodium azide Sigma 
Ammonium sulfate Sigma 
2-Mercaptoethanol Sigma 
Ficoll-400 Pharmacia, Upsala, Sweden 
Egg phosphatidyl choline Sigma 
Sodium phosphate, monobasic Sigma 
Sodium phosphate, dibasic Sigma 
Sodium chloride Sigma 
Cholesterol Sigma 
[14c]-Cholesterol Amersham, Arlington Heights, 
IL 
[ 3H]-Triolein ICN Radiochemicals, Irvine, CA 
[14c]-Tripalmitin Amersham 
Potassium chloride Mallinckrodt, Paris KY 
Calcium chloride Baker 
Magnesium sulfate Mallinckrodt 
D-Glucose Mallinckrodt 
Ascorbic Acid Sigma 
Pargyline Sigma 
Dopamine Sigma 
CHEMICALS (cont.) 
Chemical 
[ 3HJ-Dopamine 
Nomifensine 
Ecoscint 
SCH23390 
(+)-Butaclamol 
Tris-maleate 
Isobutylmethylxanthine 
EGTA 
Creatine phosphate 
Creatine kinase 
GTP 
ATP 
ANS 
DPH 
Potassium phosphate, mono-
basic 
sos 
Magnesium chloride 
Trichloroacetic acid 
Triton X-100 
2 1 ,3 1 -cAMP 
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Source 
New England Nuclear, Boston MA 
Hoechst-Roussel, Somerville, 
NJ 
National Diagnostics, 
Manville, NJ 
Research Biochemicals, Inc., 
Wayland, MA 
New England Nuclear 
Research Biochemicals, Inc. 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Molecular Probes, Inc., 
Junction City, OR 
Molecular Probes, Inc. 
Baker 
Sigma 
Sigma 
Sigma 
Aldrich Chemical, Milwaukee, 
WI 
Sigma 
CHEMICALS (cont.) 
Chemical 
sodium citrate 
rsopropanol 
Ammonia 
p-Nitrophenyl phosphate 
Ferricytochrome c 
Sodium dithionite 
Acrylamide 
bis-Acrylamide 
Glycine 
Bromothymol blue 
Ammonium persulfate 
Isobutanol 
TEMED 
Methanol 
Acetic Acid 
Coomassie blue 
anti-cAMP antibody 
Gamma-globulin 
Triethylamine 
Acetic anhydride 
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Source 
Baker 
Mallinckrodt 
Mallinckrodt 
Sigma 
Sigma 
Fisher Scientific, Fair Lawn, 
NY 
Sigma 
Eastman Kodak, Rochester, NY 
Sigma 
Sigma 
Sigma 
Eastman Kodak 
Sigma 
Baker 
Mallinckrodt 
Sigma 
Research Products Inter-
national, Mt. Prospect, IL 
Sigma 
Meloy Laboratories, Spring-
field, VA 
Sigma 
Sigma 
Sigma 
CHEMICALS (cont.) 
chemicals 
HSA 
K+-Na+ tartrate 
Source 
Sigma 
Mallinckrodt 
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CHAPTER IV 
RESULTS 
NONSPECIFIC LIPID TRANSFER PROTEIN 
Purification of Lipid Transfer Protein 
The lipid transfer protein was eluted from the 
Sephadex CM-C25 ion exchange column in a single peak which 
immediately followed a large peak containing yellow mate-
rial (Figure 9). It was necessary to extensively wash the 
column with the dialysis buffer prior to elution in order 
to achieve a good separation of the LTP peak. The purifi-
cation of LTP is represented in Table I. After the ammo-
nium sulfate precipitation, there was an increase in the 
apparent yield of transfer activity. This may have been 
due to the removal of possible endogenous inhibitors in the 
5.1 Supernatant fraction. After the ion exchange chromato-
graphy, the LTP had been purified 217-fold over the 5.1 
Supernatant. The yield of transfer activity was 53%. 
Figure 10 depicts the separation of proteins in the LTP 
fraction, the 5.1 Supernatant, and the ammonium sulfate 
fractions by SOS-PAGE. As shown in Figure 10, the 
purification of LTP yielded an enrichment of transfer 
activity and a reduction of the contaminating proteins. 
From the Rf of the molecular weight standards and the LTP 
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figure 9. The Elution of LTP from Sephadex CM-C25. 
After ammonium sulfate precipitation and dialysis, the 
aialysate was applied to a Sephadex CM-C25 ion exhange 
column and washed extensively with dialysis buffer. The 
transfer protein was eluted with 2 volumes of a solution 
containing 25 mM sodium phosphate, 45 mM NaCl, 5 mM 2-
rnercaptoethanol, and 0.02% (w/v) sodium azide. The O.D. of 
individual fractions was determined at 280 nm to follow the 
elution. The LTP peak was identified by its cholesterol 
transfer activity. 
FIGURE 9 
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TABLE I 
PURIFICATION OF LIPID TRANSFER PROTEIN 
FRACTION VOLUME PROTEIN TOTAL SPECIFIC TOTAL % YIELD PURIFICATION 
(ml) (mg/ml) PROTEIN ACTIVITY ACTIVITY 
(mg) (nmol chol 
transferred/ 
mg protein) 
5.1 
SUPERNATANT 1390 26.27 36515 0.3 10955 100 1 
AMMONIUM 
SULFATE 750 27.77 20828 0.89 18599 170 3 
CM-C25 380 0.23 88.54 65.24 5776 53 217 
Lipid Transfer Protein was partially purified from beef liver as described in the 
Materials and Methods. Aliquots of the 5.1 Supernatant, the ammonium sulfate fraction 
and the LTP fraction obtained after ion exchange chromatography on Sephadex CM-C25, 
were assayed for cholesterol transfer activity as described. 
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figure 10. SOS-PAGE of Fractions from the Purification of 
LTP. 
The separating gel contained 12.5% (w/v) acrylamide and the 
stacking gel contained 3% (w/v) acrylamide. The arrows 
indicate the LTP 
Lane 1: 
Lane 2: 
Lane 3: 
Lane 4: 
band in each experimental lane. 
5.1 Supernatant (100 µg protein) 
Ammonium Sulfate fraction (100 
LTP fraction (10 µg protein) 
Low molecular weight standards 
Phosphorylase B, 92.5 K 
Bovine Serum Albumin, 66.2 K 
Ovalbumin, 45 K 
Carbonic Anhydrase, 31 K 
µg 
Soybean Trypsin Inhibitor, 21.5 K 
Lysozyme, 14.4 K 
protein) 
FIGURE 10 
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band, the apparent molecular weight of LTP was calculated 
as 14,300 daltons (Figure 11). It was not necessary to 
continue the purification to homogeneity because the most 
important contaminating protein, a PC-specific transfer 
protein with a Pr of 5.8 (Zilversmit, 1983), would be 
expected to be removed during the ion exchange chromato-
graphy. The molecular weight of this PC-specific transfer 
protein is 28,000 daltons (Zilversmit, 1983). In the SDS-
PAGE of the LTP fraction, no bands appeared in this molecu-
lar weight region (Figure 10). 
ASSAY OF CHOLESTEROL TRANSFER ACTIVITY 
The purpose of the assay was to demonstrate a 
unidirectional transfer of cholesterol from a donor lipo-
some into mitochondria. The mitochondrial membrane is a 
good acceptor because it contains very little cholesterol. 
The amount of cholesterol in the mitochondrial membrane 
preparation was below the limits of detection for the 
cholesterol assay. The liposomes used in the assay con-
tained PC and cholesterol (1:1, mole:mole) as well as 
[ 3H]-triolein and [ 14c]-cholesterol. After the incuba-
tion, the mitochondria will have a 14c/ 3H that is 
greater than the 14c; 3H of the liposomes, if a net 
transfer of cholesterol has taken place. An assumption 
that must be made is that the 14c, 3H, and cholesterol 
in these liposomes are uniformly distributed throughout the 
population of liposomes. In order to show this, the 
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figure 11. Sodium Dodecyl Sulfate Polyacrylamide Gel 
Electrophoresis of the LTP Sample. 
From the Rf of the LTP band after SDS-PAGE on a 12.5% 
acrylamide gel, the apparent molecular weight of LTP was 
determined to be 14,300 daltons. 
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liposomes were chromatographed on Sepharose 4B-CL. Each 
fraction was assayed for phospholipid phosphorus and 
cholesterol, and the radioactivity was determined by liquid 
scintillation counting. The distrubution of lipid and 
radioactivity in the liposomes for the transfer assay is 
shown in Figure 12. One population of liposomes is found. 
The phosphorus (Pi), cholesterol, 3H, and 14c coeluted, 
indicating that the liposomes were uniform in composition. 
The results of a typical transfer assay using beef 
heart mitochondria is shown in Figure 13. The nonspecific 
transfer increased linearly over the time assayed and 
accounted for approximately 20% of the total cholesterol 
transferred. The specific transfer was nearly linear for 
up to 25 minutes. 
RELATIVE PURITY OF SYNAPTOSOMES AND SPM 
RAT WHOLE BRAIN MEMBRANES 
Rat whole brain synaptosomes and SPM were pre-
pared. The relative purity of these fractions, as compared 
to homogenates, is shown in Table II. Each determination 
is the average of tissue from four preparations. Na+-
K+-ATPase, found primarily in plasma membranes, was en-
riched in both the synaptosomal and SPM fractions, 1.7- and 
4.7-fold, respectively. The relative specific activities 
of acid phosphatase, cyctochrome c oxidase, and CNPase dem-
onstrate a significant reduction in the contamination of 
the synaptosomal and SPM preparations by lysosomal, mito-
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figure 12. Sepharose 4B-CL Chromatography of Liposomes 
used for Cholesterol Transfer Assay. 
Liposomes were prepared containing 1 mg PC/ml and 1 mole of 
cholesterol per mole of PC. [ 14c]-Cholesterol was 
included as a transferrable marker. [ 3H]-Triolein was 
included as a nontransferrable marker. One ml of liposomes 
was loaded onto the column (1 x 15 cm) and was eluted with 
20 ml of 50 mM Tris HCl, pH 7.4. One ml fractions were 
collected and assayed for cholesterol and phospholipid 
phosphorus. The radioactivity in each fraction was 
determined by liquid scintillation counting. 
FIGURE 1 2 
60 
50 
40 
30 
20 
10 
o~-----~~;£.--.-~--=~~;;;;;ii;;;;;;;~=--=iio=mii--ii--fil 
0 5 10 15 
FRACTION 
-e- 14C DPM X 1000 
-*- 3H DPM X 1000 
-9- Pi nmol/100 ul 
-+- CHOL nmol/100 ul 
CD 
N 
83 
Figure 13. Cholesterol Transfer Activity of Purified LTP. 
cholesterol transfer activity was assayed by incubating 
heat-treated mitochondria with LTP and [ 14c)- and 
[3HJ-labelled liposomes for varying time periods at 
32°c. The reaction was terminated by filtration through 
GF/C filters, followed by 3 washes with 5 ml of 50 mM Tris 
HCl, pH 7.4. Nonspecific transfer was determined in the 
absence of LTP. The radioactivity associated with the 
filters was determined by liquid scintillation counting. 
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TABLE III 
ACTIVITY OF ENZYME MARKERS IN BOVINE BRAIN SYNAPTOSOMES AND SYNAPTIC PLASMA MEMBRANES 
Na+K+ATPase 
µg Pi released/hr/ 
mg protein 
Relative specific activity 
Acid Phosphatase 
nmole substrate hydrolyzed/ 
hr/mg protein 
Relative specific activity 
HOMOGENATE 
2.89 +/- 0.79 
1 
13.49 +/- 1. 85 
1 
SYNAPTOSOME SPM 
4.91 +/- 0.49* 12.73 +/- 4.73** 
1. 70 4.40 
12.65 +/- 1.95 10.34 +/- 3.67 
0.94 0.77 
cytochrome c Oxidase 0.555 +/- 0.017 0.260 +/- 0.080* 0.100 +/- 0.030** 
µmole substrate hydrolyzed/ 
min/mg protein 
Relative specific activity 1 0.47 0.18 
CNPase 1665.3 +/- 120.6 1049.5 +/- 110.9** 818.8 +/- 193.4** 
µmole product formed/hr/ 
mg protein 
Relative specific activity 1 0.63 0.49 
Na+K+ATPase (plasma membranes), acid phosphatase (lysosomes), cytochrome c oxidase 
(mitochondria), and CNPase (myelin) assays were performed on samples from 4 individual 
membrane preparations. The relative specific activity is used to compare the specific 
activities of synaptosomes and SPM to that of the homogenates. Values of greater than 
one represent enrichment of the enzyme activity. 
* Values are statistically different from the homogenates at P<.05. 
** Values are statistically different from the homogenates at P<.01. (X) 
U1 
chondrial, and myelin membranes, respectively. 
BOVINE CAUDATE MEMBRANES 
86 
Bovine caudate synaptosomes and SPM were initially 
prepared following the method of Cotman and Matthews (1971) 
(Figure 6). The myelin fraction was not well separated in 
the Ficoll gradient or the sucrose gradient. Because of 
the high cholesterol content and microviscosity of the my-
elin membrane, it is desirable to minimize the contamina-
tion of the synaptosomal and SPM preparations with myelin. 
Thus, the gradients used to isolate synaptosomes and SPM 
were modified as described in the Materials and Methods. 
This allowed the isolation of relatively pure fractions. 
The relative purity of synaptosomes and SPM pre-
pared using the modified method is compared to membrane 
homogenates (Table III). Each determination is the average 
of four separate preparations. Na+-K+-ATPase was 
enriched in both the synaptosomal and SPM fractions, 1.7-
and 4.4-fold, respectively. The relative specific activ-
ities of cytochrome c oxidase and CNPase demonstrate a 
significant reduction in the contamination of synaptosomal 
and SPM preparations by mitochondrial and myelin membranes, 
respectively. However, the CNPase activity in each of the 
bovine caudate fractions was approximately 6-fold higher 
than that found in rat whole brain (Table II). The 
contamination by lysosomal membranes, as identified by the 
activity of acid phosphatase, was not significantly 
TABLE II 
ACTIVITY OF ENZYME MARKERS IN RAT BRAIN SYNAPTOSOMES AND SYNAPTIC PLASMA MEMBRANES 
HOMOGENATE SYNAPTOSOME SPM 
Na+K+ATPase 4.64 +/- 1.15 7.97 +/- 1. 92* 21. 87 +/- 3.14** 
µg Pi released/hr/ 
mg protein 
Relative specific activity l 1. 72 4.74 
Acid Phosphatase 18.18 +/- 2.12 15.23 +/- 2.10* 8.95 +/- 0.76+·w 
nmole substrate hydrolyzed/ 
hr/mg protein 
Relative specific activity l 0.84 0.49 
Cytochrome c oxidase 0.675 +/- 0.064 1.195 +/- 0.040* 0.192 +/- 0.031** 
µmole substrate hydrolyzed/ 
min/mg protein 
Relative specific activity l 0.29 0.18 
CNPase 291.0 +/- 37.8 135.2 +/- 32.2* 128.0 +/- 17.3** 
,umole product formed/hr/ 
mg protein 
Relative specific activity l 0.46 0.44 
Na+K+ATPase (plasma membranes), acid phosphatase (lysosomes), cytochrome c oxidase 
(mitochondria), and CNPase (myelin) assays were performed on samples from 4 individual 
membrane preparations. The relative specific activity is used to compare the specific 
activities of synaptosomes and SPM to that of the homogenates. Values of greater than 
one represent enrichment of the enzyme activity. 
* Values are statistically different from the homogenates at P<.05. 
** Values are statistically different from the homogenates at P<.01. 
different from the homogenates. 
CHOLESTEROL TRANSFER 
RAT WHOLE BRAIN MEMBRANES 
88 
Accurate calculation of the Chol/PL in all experi-
mental membranes required the correction of cholesterol and 
phosphorus content for the sticking of liposomes. The in-
clusion of [ 14c]-tripalmitin in the liposomes made this 
correction possible. However, in order for this correction 
to be accurate, the cholesterol, PL, and 14 c label must 
be uniformly distributed throughout the liposome popula-
tion. The analysis of the fractions from Sepharose 4B-CL 
chromatography of PC and PC-Chol liposomes is shown in 
Figures 14 and 15, respectively. Two populations of PC 
liposomes were found, due to the high concentration of PC 
{10 mg/ml). The radioactivity eluted with the phosphorus. 
One population of PC-Chol liposomes was found. Phosphorus, 
cholesterol, and radioactivity were coeluted from the 
column. These results suggest that, in both the PC and 
PC-Chol liposomes, the radioactivity was associated with 
the liposomes and the correction for liposome sticking was 
accurate. 
The analysis of rat whole brain SPM from a typical 
lipid transfer experiment is shown in Table IV. The change 
in Chol/PL was paralleled by a change in cholesterol/pro-
tein. Although the PL/protein was slightly increased, this 
change, which was up to 10.55% of control, was small when 
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Figure 14. Sepharose 4B-CL Chromatography of PC Liposomes 
used for Cholesterol Transfer. 
pc liposomes, prepared in sucrose buffer, contained 10 ml 
pc/ml. One ml of liposomes was loaded onto the column {1 x 
15 cm) and eluted with 20 ml of sucrose buffer. One ml 
fractions were collected and assayed for phospholipid 
phosphorus. The radioactivity in each fraction was 
determined by liquid scintillation counting. 
Figure 15. Sepharose 4B-CL Chromatography of PC-Chol Lipo-
somes used for Cholesterol Transfer 
PC-chol liposomes, containing 5 ml PC/ml and 1.7 mole of 
cholesterol per mole of PC, were chromatographed as 
described in Figure 14. The fractions were assayed for 
phospholipid phosphorus and cholesterol. The radioactivity 
in each fraction was determined by liquid scintillation 
counting. 
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TABLE IV 
CHOLESTEROL DEPLETION AND LOADING OF RAT BRAIN SPM 
ANALYSIS OF LIPID-MODIFIED SPM 
TYPE OF 
LIPOSOME 
USED 
CHOL 
PROTEIN 
nmole 
mg 
__N, __ 
PROTEIN 
nmole 
mg 
CHOL 
PL 
mole 
mole 
CHANGE IN % CHANGE 
CHOL 
CHANGE IN 
PL 
nmole 
% CHANGE 
nmole 
mg protein mg protein 
PC 378 985 .384 -137 -26.60 +18 +1.86 
PC 410 967 .424 -105 -20.39 0 0 
PC 465 1056 .440 -50 -9.71 +89 +9.20 
NONE * 515 967 .533 0 0 0 0 
PC-CHOL 633 975 .649 +118 +22.91 +8 +0.82 
PC-CHOL 744 1032 .720 +229 +44.47 +65 +6.72 
PC-CHOL 938 1069 .878 +423 +82.14 +102 +10.55 
The results presented are from a typical cholesterol transfer experiment using SPM. 
Similar results were obtained using synaptosomes. SPM were incubated with liposomes 
and varying amounts of transfer protein, from 0.1 to 0.4 mg per ml of incubation 
mixture. PC liposomes were used for cholesterol depletion. PC-CHOL liposomes were 
used for cholesterol loading. All membranes were assayed for protein, cholesterol, 
phospholipid phosphorus. Also, the sticking of liposomes to the membranes was 
corrected for by the inclusion of [14c)-tripalmitin in the liposomes. All values 
presented are after the correction for the sticking of liposomes. The changes in 
cholesterol and phospholipid are as compared to the control (*), which was incubated 
without liposornes. 
and 
92 
compared to the change in cholesterol/protein, which is up 
to 82.14%. As shown in Table IV, the alteration of the 
cholesterol content of SPM using LTP was effective with 
little change in the phospholipid composition of the mem-
branes. 
BOVINE CAUDATE MEMBRANES 
The analysis of bovine caudate SPM from a typical 
lipid transfer experiment is shown in Table v. The change 
in Chol/PL was paralleled by the change in Chol/protein. 
The PL/protein was slightly altered. 
FLUORESCENCE POLARIZATION 
RAT WHOLE BRAIN MEMBRANES 
The hydrophobic core of the membrane was probed 
with DPH. When incorporated into SPM, the magnitude of the 
DPH fluorescence signal was proportional to the amount of 
SPM lipid present. The polarization (P) value was inde-
pendent of the lipid and protein concentration. The most 
reproducible P values were obtained at a membrane protein 
concentration of 50 pg per 3 ml. Fluorescence polarization 
and anisotropy (r) values decreased with increasing temper-
ature (Figure 16) . A decrease in P or r indicates a de-
crease in the relative microviscosity (Figure 17). Arrhen-
ius plots of the DPH anisotropy (Figure 16) of cholesterol-
depleted and cholesterol-loaded membranes, having Chol/PL 
of 0.366 and 0.878, respectively, showed no discontinuities 
TABLE V 
CHOLESTEROL DEPLETION AND LOADING OF BOVINE BRAIN SPM 
ANALYSIS OF LIPID-MODIFIED SPM 
TYPE OF CHOL PL CHOL CHANGE IN % CHANGE CHANGE IN 
PL 
nmole 
% CHANGE 
LIPOSOME PROTEIN PROTEIN PL CHOL 
USED nmole nmole mole nmole 
mg mg mole mg protein mg protein 
PC 386 1031 .375 -166 -30.07 +23 +2.28 
PC 430 999 .430 -122 -22.10 -9 -0.89 
PC 495 1020 .485 -57 -10.33 +12 +l.19 
NONE * 552 1008 .547 0 0 0 0 
PC-CHOL 625 1009 .619 +73 +13.22 +l +0.10 
PC-CHOL 713 1023 .697 +161 +29.17 +15 +l. 49 
PC-CHOL 844 1012 .834 +292 +52.90 +4 +0.40 
The results presented are from a typical cholesterol transfer experiment using SPM. 
Similar results were obtained using synaptosomes. SPM were incubated with liposomes 
and varying amounts of transfer protein, from 0.1 to 0.4 mg per ml of incubation 
mixture. PC liposomes were used for cholesterol depletion. PC-CHOL liposomes were 
used for cholesterol loading. All membranes were assayed for protein, cholesterol, 
phospholipid phosphorus. Also, the ~ticking of liposomes to the membranes was 
corrected for by the inclusion of ( 1 C]-tripalmitin in the liposomes. All values 
presented are after the correction for the sticking of liposomes. The changes in 
cholesterol and phospholipid are as compared to the control {*),which was incubated 
without liposomes. 
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figure 16. Arrhenius Plots of DPH Anisotropy in Rat 
Brain SPM 
DPH anisotropy (r) was calculated from polarization (P) 
values measured at 4°c, 15°c, 25°c, 37°c, and 5o0 c. 
Representative plots for cholesterol-depleted (Chol/PL = 
o.366, o ), control (Chol/PL= 0.553,x ), and cholesterol-
loaded (Chol/PL= 0.878, v) membranes are shown. 
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figure 17. The Relative Microviscosity of the Hydrophobic 
Core of Rat Brain SPM as a Function of Chol/PL. 
The relative microviscosity was calculated from DPH r 
values measured at 4 °c ( o ) , 15°c ( x ) , 2s0 c ( v ) , 
31°c ( * ) , and so 0 c ( o). The Chol/PL of control SPM 
is 0.543 +/- 0.014 (n = 4). Chol/PL of 0.35 to 0.706 could 
be considered physiological. The lines were generated to 
fit a theoretical sigmoidal curve that approximated the 
experimental data. 
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suggestive of a sharp phase transition over the temperature 
range of 4°C to 5o0 c. In contrast, the Arrhenius plot 
of the DPH anisotropy of the control membrane was curvi-
linear with limiting slopes at the low and high tempera-
tures similar to those of the high and low cholesterol-
containing membranes respectively. 
The relationship between the relative micro-
viscosity of the hydrophobic core of rat whole brain SPM 
and Chol/PL is shown in Figure 17. The DPH data appeared 
to fit a sigmoidal relationship, with an inflection point 
at a Chol/PL of 0.58. In the range of Chol/PL of 0.5 to 
0.65, there was an increase in the relative microviscosity 
at each temperature studied. At Chol/PL above and below 
this range, the relative microviscosity was relatively 
independent of Chol/PL. At 37°c, a 10% increase in 
Chol/PL produced a 75% increase in the relative microvis-
cosity. A further increase in Chol/PL produced a smaller 
effect. A similar decrease in Chol/PL produced a change in 
the relative microviscosity of 30%. The greatest change in 
the relative microviscosity occurred in the range of 
Chol/PL of 0.5 to 0.6. The Chol/PL of control rat whole 
brain SPM was 0.543 +/- 0.014 (n = 4). 
The membrane surface was probed with ANS. Because 
ANS binds to proteins as well as to lipids in the membrane, 
it was important to establish the assay conditions which 
would optimize the signal from the lipid-bound ANS. At 
99 
lower concentrations of ANS, up to 100 µM, the wavelength 
of the emission maximum was 480 nm. This wavelength is 
characteristic of ANS bound to proteins (Slavik, 1982). 
Above 200 µM ANS, the wavelength of the emission maximum 
was 495 nm. At this concentration, the fluorescence signal 
would be expected to be due to ANS bound primarily to 
lipids (Slavik, 1982). This was further verified by the 
wavelength of the emission maximum of ANS bound to lipo-
somes, 495 nm. A membrane protein concentration of 100 µg 
per 3 ml was found to produce the most reproducible P 
values. 
As seen with the DPH probe, the anisotropy (r) 
values decreased with increasing temperature (Figure 18). 
This indicates an increase in relative microviscosity 
(Figure 19). Arrhenius plots of ANS anisotropy (Figure 18) 
of control, cholesterol-depleted, and cholesterol-loaded 
membranes, having Chol/PL of 0.384. 0.553, and 0.782, 
respectively, showed a response to temperature similar to 
that observed with the control membranes using DPH over the 
temperature range of 4°c to 37°c. Also, the plots for 
membranes with Chol/PL of 0.553 and 0.782 are nearly super-
imposable, suggesting that increasing the Chol/PL had 
little effect on the relative microviscosity at the mem-
brane surface (Figure 19). A small temperature range was 
studied because as the temperature was increased, the mag-
nitude of the fluorescence signal decreased sharply. 
ioo 
Figure 18. Arrhenius Plots of ANS Anisotropy in Rat 
Brain SPM. 
ANS anisotropy (r) was calculated from P values measured at 
4oc, 2s0 c, and 37°c. Representative plots for cholesterol-
depleted (Chol/PL = O. 3 84, O ) , control (Chol/PL = 
o. 553, x ) , and cholesterol-loaded (Chol/PL = O. 782, v ) 
membranes are shown. 
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figure 19. The Relative Microviscosity of the Surface of 
Rat Brain SPM as a Function of Chol/PL. 
The relative microviscosity was calculated from ANS r 
values measured at 4°C ( o), 25°c ( x ) , and 37°c 
( v ) . The Chol/PL of control SPM is O. 543 +/- o. 014 (n = 
4). Chol/PL of 0.35 to 0.706 could be considered 
physiological. The lines were generated to fit a 
theoretical sigmoidal curve that approximated the 
experimental data. 
FIGURE 19 
D 
D -;:;---i::r-------_JD 
D D 
x x 
x 
x 'V 
x 
o~~i;-~~~---.-. .7 ---, 
.3 .4 .5 6 
CHOL/PL ·
8 
.9 
--a- 4 c 
-x- 25 c 
-'V- 37 c 
..... 
0 
l.J 
104 
The relationship between the relative micro-
viscosi ty at the membrane surface and Chol/PL is shown in 
Figure 19. The ANS data also appeared to fit a sigmoidal 
relationship. However, the inflection point was at a Chol/ 
PL of 0.50. In the range of Chol/PL of 0.45 to 0.6, there 
was an increase in relative microviscosity at each tempera-
ture studied. At Chol/PL above and below this range, the 
relative microviscosity was independent of Chol/PL. At 
37°c, the overall change was less dramatic than was seen 
with DPH. The greatest change occurred in the range of 
Chol/PL of 0.5 to 0.6. The Chol/PL of control SPM was 
0.543 +/- 0.014 (n = 4). 
Comparing the hydrophobic core (Figure 17) and the 
membrane surface (Figure 19), at each Chol/PL, the relative 
microviscosity of the hydrophobic core of the membrane was 
greater than that at the surface. However, above a Chol/PL 
of 0.6, the difference was much greater. The core of the 
membrane was much more rigid than the surface at high Chol/ 
PL. As seen in Figures 19 and 17, respectively, the mem-
brane surface was more sensitive to decreases in Chol/PL, 
while the hydrophobic core was more sensitive to increases 
in Chol/PL. 
BOVINE CAUDATE MEMBRANES 
Bovine caudate SPM were assayed in the fluores-
cence studies as described for rat brain SPM. The hydro-
phobic core of the membrane was probed with DPH. Polariza-
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tion (P) and anisotropy (r) values decreased with increas-
ing temperature (Figure 20), indicating a decrease in 
microviscosity (Figure 21). Arrhenius plots of the DPH 
anisotropy (Figure 20) of control, cholesterol-depleted, 
and cholesterol-loaded membranes, having Chol/PL of 0.547, 
0.345, and 0.881, respectively, were curvilinear, with the 
greatest curvature evident at the lowest Chol/PL, 
suggesting that any change in state of the interior of the 
bovine caudate SPM would be most evident at lower Chol/PL. 
The relationship between the relative microvis-
cosi ty of the hydrophobic core of bovine caudate SPM and 
Chol/PL is shown in Figure 21. The bovine SPM did not 
exhibit the same sigmoidal relationship as did the SPM from 
rat brain. This may have been due to the higher amounts of 
cholesterol-rich myelin that were present in the prepara-
tions (Table III). As the Chol/PL was decreased from 0.6, 
there was a decrease in microviscosity at each temperature 
studied. The greatest decrease occurred at lower 
temperatures (4°c and 15°c) and smallest at 5o 0 c. 
Furthermore, at the lower temperatures, the midpoint of the 
transition in microviscosity occured at Chol/PL below the 
physiological, as expected from the Arrhenius plot. At 
37°c, increasing the Chol/PL produced only a gradual 
increase in microviscosity with a maximal change over the 
range studied of 170%. Furthermore, no dramatic changes in 
the relative microviscosity are seen in the region of the 
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Figure 20. Arrhenius Plots of DPH Anisotropy in Bovine 
Caudate SPM. 
DPH anisotropy (r) was calculated from P values measured at 
4°c, 15°c, 25°c, 37°c, and 5o0 c. Representative 
plots for cholesterol-depleted (Chol/PL= 0.345,o ), 
control (Chol/PL= 0.547, x) and cholesterol-loaded 
(Chol/PL = 0.881, ~) membranes are shown. 
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figure 21. The Relative Microviscosity of the Hydrophobic 
Core of Bovine Caudate SPM as a Function of 
Chol/PL. 
The relative microviscosity was calculated from DPH r 
values measured at 4°c ( o), is0 c ( x), 2s0 c ( v), 
37oc ( * ) , and so0 c ( <> ) • The Chol/PL of control SPM 
was 0.542 +/- 0.026 (n = 4). Chol/PL of 0.30 to 0.705 
could be considered physiological. 
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physiological Chol/PL, which had a value of 0.542 +/- 0.026 
(n = 4). 
The membrane surface was probed with ANS. Bovine 
caudate SPM were assayed under conditions identical to 
those used to study the rat whole brain SPM. As with DPH, 
the ANS anisotropy (r) values decreased with increasing 
temperature (Figure 22), corresponding to a decrease in 
relative microviscosity (Figure 23). Arrhenius plots of 
ANS anisotropy (Figure 22) of control, cholesterol-de-
pleted, and cholesterol-loaded SPM, having Chol/PL of 
0.504, 0.351, and 0.834, respectively, were similar to 
those observed for the rat membranes. 
The relationship between the relative micro-
viscosi ty at the membrane surface and Chol/PL is shown in 
Figure 23. As with DPH, there was a decrease in the rela-
tive microviscosity as the Chol/PL decreased from 0.6. At 
Chol/PL above this point, no further change in microviscos-
ity was detected. At 37°c, increasing the Chol/PL 
produced only a small increase in the relative microvis-
cosity, up to 20% over the control. However, decreasing 
the Chol/PL to 0.46 produced a 52% decrease in the relative 
microviscosity. Again, the midpoint of the change in the 
surface microviscosity occurred at a Chol/PL below the 
physiological value of 0.542 +/- 0.026 (n = 4). 
Comparing the hydrophobic core (Figure 21) and the 
surface (Figure 23) of bovine caudate SPM, at each Chol/PL, 
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figure 22. Arrhenius Plots of ANS Anisotropy in Bovine 
Caudate SPM. 
ANS anisotropy (r) was calculated from P values measured at 
4oc, 2s0 c, and 37°c. Representative plots for cholesterol-
depleted (Chol/PL= 0.351,D ), control (Chol/PL= 
o.504,x ), and cholesterol-loaded (Chol/PL= 0.834, v) 
membranes are shown. 
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figure 23. The Relative Microviscosity of the Surface of 
Bovine Caudate SPM as a Function of Chol/PL. 
The relative microviscosity was calculated from ANS r 
values measured at 4°C ( o), 25°c ( x), and 37°c 
(v). The Chol/PL of control SPM was 0.542 +/- 0.026 (n = 
4)· Chol/PL of 0.30 to 0.705 could be considered 
physiological. 
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the relative microviscosity of the hydrophobic core of the 
membrane was greater than that at the membrane surface. In 
contrast to rat whole brain SPM (Figures 17 and 19), the 
surface and hydrophobic core of bovine caudate SPM were af-
fected by the presence of cholesterol in a similar way. 
Both regions of the membrane were more sensitive to de-
creases in Chol/PL than to increases in the Chol/PL at 
values near that of the control (Figures 21 and 23). 
DOPAMINE UPTAKE STUDIES USING RAT WHOLE BRAIN MEMBRANES 
The uptake of [ 3HJ-dopamine into control, cho-
lesterol-depleted, and cholesterol-loaded rat whole brain 
synaptosomes was studied. Each experimental set of five 
samples included synaptosomes which had been incubated with 
PC liposomes or PC-Chol liposomes, using two concentra-
tions of LTP for each type of liposome. A control was in-
cluded in each set, which was incubated under standard con-
ditions, except that sucrose buffer was substituted for the 
liposomes. 
A typical assay for control synaptosomes is shown 
in Figure 24. For control samples, a concentration range 
of 10-1000 nM dopamine was sufficient to show saturation. 
Nonspecific uptake, determined in the presence of 10 µM 
nomifensine, typically accounted for 15-25% of the total 
radioactivity bound. The Rm was calculated from the X-
intercept and the Vmax from the slope of the Hanes plot 
(s/v vs. s) (Figure 24, insert). For the typical control 
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Figure 24. Kinetics of Dopamine Uptake into Control Rat 
Brain Synaptosomes. 
The uptake of dopamine into control synaptosomes was 
assayed in triplicate using 10-15 nM ( 3H]-dopamine and 7 
concentrations of unlabelled dopamine ranging from 0-1000 
nM . Nonspecific binding, determined in the presence of 10 
µM nomifensine, accounted for 15-25% of the total uptake 
detected. A typical assay is shown. From the Hanes plot, 
which is the substrate concentration/the observed rate 
versus the substrate concentration (s/v vs. s) (insert), 
the control ~ (135.7 nM) and the Vmax (8.81 pmole/mg 
protein/5 min assay) were determined. The Chol/PL of 
control synaptosomes is 0.440 +/- 0.040 (n = 11). 
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assay shown, the Km was 135.7 nM, and the Vmax was 8.81 
pmole/mg protein/5 minute assay. The Chol/PL of control 
synaptosomes was 0.440 +/- 0.040 (n = 11). 
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The effect of cholesterol loading on the Km for 
dopamine uptake is illustrated in Figure 25. Each point 
represents an individual uptake experiment. Only assays 
with at least 5 data points and a correlation coefficient 
of 0.9 or better for the linear fit of the Hanes plot were 
included. As shown in Figure 25, the Km began to sharp-
ly increase as the Chol/PL was increased above 0.5. 
Chol/PL above 0.6 are not physiological. But within the 
physiological range of Chol/PL, the increase in Km was 
3-fold. Decreasing the Chol/PL from the control value 
produced an approximately 50% decrease in the Km· 
The Vmax for uptake showed a similar relation-
ship to Chol/PL (Figure 26). Each point represents an in-
dividual uptake experiment. Only assays with at least 5 
data points and a correlation coefficient of 0.9 or better 
for the linear fit of the Hanes plot were included. At 
Chol/PL above 0.5, there was a sharp increase in the 
Vmax' reaching a plateau above Chol/PL of 0.6. Decreas-
ing the Chol/PL produced an approximately 35% decrease in 
the Vmax· 
The Vmax/Km, a first order rate constant for 
the uptake transporter at low substrate concentrations 
(Cornish-Bowden, 1979), was calculated for each assay in-
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figure 25. The Km for Dopamine Uptake as a Function of 
Chol/PL. 
oopamine uptake was assayed in cholesterol-depleted, 
control, and cholesterol-loaded synaptosomes. Each assay 
consisted of triplicate determinations using 10-15 nM 
[3HJ-dopamine and 7 concentrations of unlabelled 
dopamine, ranging from 0-1000 nM for control and choles-
terol depleted membranes, and 0-5000 nM for cholesterol-
loaded membranes. The Km was calculated from the 
x-intercept of the Hanes plot (s/v vs. s). Each point 
represents an individual uptake assay. Only assays with at 
least 5 concentration points and a correlation coefficient 
of 0.9 or better for the linear fit of the Hanes plot were 
included. The Chol/PL of control synaptosomes was 0.440 
+/- 0.040 (n = 11). Chol/PL of 0.29 to 0.572 could be 
considered physiological. The error bar represents the 
mean +/- standard deviation of Km values at control 
Chol/PL. 
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figure 26. The Vmax for Dopamine Uptake as a Function of 
Chol/PL. 
Dopamine uptake was assayed in cholesterol-depleted, 
control, and cholesterol-loaded synaptosomes. Each assay 
consisted of triplicate determinations using 10-15 nM 
[3HJ-dopamine and 7 concentrations of unlabelled dopamine 
ranging from 0-1000 nM for control and cholesterol-depleted 
membranes, and 0-5000 nM for cholesterol-loaded membranes. 
The Vmax was calculated from the slope of the Hanes plot 
(s/v vs. s). Each point represents an individual uptake 
assay. Only assays with at least 5 concentration points 
and a correlation coefficient of 0.9 or better for the 
linear fit of the Hanes plot were included. The Chol/PL of 
control synaptosomes is 0.440 +/- 0.040 (n = 11). Chol/PL 
of 0.29 to 0.572 could be considered physiological. The 
error bar represents the mean +/- standard deviation of 
Vmax values at control Chol/PL. 
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eluded in Figures 25 and 26. The relationship between 
Vmaxl~ and Chol/PL is shown in Figure 27. For Chol/PL 
between 0.5 and 0.7, the Vmaxl~ decreased with in-
creasing Chol/PL. At Chol/PL below 0.5 and above 0.7, 
there was no change in Vmaxl~ with changes in Chol/PL. 
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Because the Chol/PL of control SPM and synapto-
somes were different, 0.543 +/- 0.014 (n = 4) and 0.440 +/-
0.040 (n = 11), respectively, it may be helpful to use the 
percent change in Chol/PL to compare the relative microvis-
cosity with the biological effect. The relative microvis-
cosity of the hydrophobic core increased sharply at a Chol/ 
PL 10-15% above the control (Figure 28). As the Chol/PL 
was increased 30%, which can be considered the upper limit 
of the physiological range of Chol/PL, the relative 
microviscosity of the membrane core was about 2-fold 
greater than control, while that at the membrane surface 
was increased 20%. Over this same range of Chol/PL, the 
Vmaxl~ decreased 33% (Figure 29). As the Chol/PL was 
decreased 40%, the relative microviscosity of the membrane 
core decreased 20% while that at the surface decreased 
50%. Little change in the Vmaxl~ was observed over 
this range of Chol/PL. 
SUMMARY OF STUDIES WITH RAT WHOLE BRAIN MEMBRANES 
Decreasing the Chol/PL produced a decrease in the 
relative microviscosity at the surface as well as in the 
hydrophobic core. Because of the sigmoidal relationship 
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figure 27. Vmax/Km for Dopamine Uptake as a Function of 
Chol/PL 
Each point represents the Vmax/Km for dopamine uptake. 
The Km and Vmax were calculated from the X-intercept 
and slope, respectively, of the Hanes plot (s/v vs. s). 
only assays with at least 5 concentration points and a 
correlation coefficent of 0.9 or better for the linear fit 
of the Hanes plot were included. The Chol/PL of control 
synaptosomes was 0.440 +/- 0.040 (n = 11). Chol/PL of 0.29 
to o.572 could be considered physiological. The error bar 
represents the mean +/- standard deviation of VmaxlI<m 
values at control Chol/PL. 
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Figure 28. The Relative Microviscosity of the Membrane 
Surf ace and Hydrophobic Core as a Function of the 
Percent Change in Chol/PL. 
The relative microviscosity of the membrane surfacn 
(ANS, o ) and core ( DPH, x ) were calculated from r values 
determined at 37°C. The Chol/PL of control SPM was 0.543 
+/- 0.014 (n = 4). A change in Chol/PL of -50% to 30% 
could be considered physiological. The lines were 
generated to fit a theoretical sigmoidal curve that 
approximated the experimental data. 
Figure 29. Vmaxl!Sn for Dopamine Uptake as a Function of 
the Percent Change in Chol/PL. 
Each point represents the Vmaxl!Sn for and individual 
dopamine uptake assay. The ISn and Vmax were calculated 
from the X-intercept and slope, respectively, of the Hanes 
plot (s/v vs. s). Only assays with at least 5 concentra-
tion points and a correlation coefficient of 0.9 or better 
for the linear fit of the Hanes plot were included. The 
Chol/PL of control synaptosomes was 0.440 +/- 0.040 (n = 
11). A change in Chol/PL of -50% to 30% could be 
considered physiological. 
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observed, the range of Chol/PL that correlated with the 
greatest change in relative microviscosity was near the 
physiological Chol/PL. Decreases in Chol/PL that were 
outside the physiological range produced little additional 
effect on the relative microviscosity. An increase in 
Chol/PL produced an increase in the relative microviscosity 
of both regions of the membrane, although the magnitude of 
the increase was greater in the hydrophobic core than at 
the membrane surface (Figure 28). 
The Km for dopamine uptake began to increase 
sharply as the Chol/PL was increased, producing a 3-fold 
increase within the physiological range of Chol/PL. At 
higher, nonphysiological Chol/PL, the increase was 8- to 
10-fold. Decreasing the Chol/PL, within the physiological 
range, produced a 50% decrease in the Km (Figure 25). 
The Vmax showed a similar relationship to Chol/PL (Figure 
26), increasing 3.5-fold as the Chol/PL was increased and 
decreasing 35% as the Chol/PL was decreased. The Vmaxl 
Km was unaffected as the Chol/PL was decreased, but de-
creasee about 33% as the Chol/PL was increased (Figure 
27). At Chol/PL above 0.8, no additional effect was ob-
served in Km, Vmax' or VmaxlI<m· 
DOPAMINE CQ1 ) BINDING STUDIES USING BOVINE CAUDATE MEMBRANES 
The binding of [ 3H]-SCH23390 to control, cho-
lesterol-depleted, and cholesterol-loaded bovine caudate 
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synaptosomes was studied. Each experimental set of seven 
samples included membranes incubated with PC liposomes or 
PC-Chol liposomes, using three concentrations of LTP for 
each type of liposome. A control, incubated with sucrose 
buffer instead of liposomes, was included with each set. 
Before beginning the binding studies, the 
SCH-23390 binding assay was optimized in this laboratory. 
Because preliminary experiments found the Ka to be in the 
range of 1 nM, a concentration range of 0.2 to 5.1 nM was 
chosen for the kinetic assays. The optimal membrane pro-
tein concentration was determined to be 300-400 ug protein 
per 3 ml assay volume. 
A typical binding assay, using control membranes, 
is shown in Figure 30. For control assays, a concentration 
range of 0.2 to 5.1 nM SCH23390 was sufficient to show sat-
uration (Figure 30). Nonspecific binding, determined in 
the presence of 1 pM (+)-butaclamol, typically accounted 
for 10-15% of the total radioactivity bound. The Ka was 
calculated from the slope, and the Bmax from the X-
intercept of the Scatchard plot (bound/free vs. bound) 
(Figure 30, insert). For the typical control assay shown, 
the Ka was 1.242 nM and the Bmax was 0.261 pmole/mg 
protein. 
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figure 30. Kinetics of SCH23390 Binding to Control Bovine 
Caudate Synaptosomes. 
The binding of SCH23390 to control synaptosomes was assayed 
in duplicate using 0.2-0.5 nM of [ 3HJ-SCH23390 and 7 
concentrations of unlabelled SCH23390 ranging from 0-5.1 
nM. Nonspecific binding, determined in the presence of 1 
µM (+)-butaclamol, accounted for 10-15% of the total 
binding. From the Scatchard plot, bound/free vs. bound 
(insert), the control Ka (1.242 nM) and the Bmax (0.261 
pmole/mg protein) were determined. The Chol/PL of control 
synaptosomes was 0.556 +/- 0.013 (n = 8). 
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The effect of altering the membrane Chol/PL on the 
Kd of SCH23390 binding is illustrated in Figure 31. Each 
point represents an individual binding experiment. Only 
assays with at least 5 data points and a correlation co-
efficient of 0.9 or better for the linear fit of the Scat-
chard plot were included. There appeared to be a trend 
toward a decreased Kd as the Chol/PL was increased. The 
change in Kd over the entire range of Chol/PL appeared to 
be about 3-fold. 
The Bmax for SCH23390 binding, as a function of 
Chol/PL, is shown in Figure 32. Each point represents an 
individual binding experiment. Only assays with at least 5 
data points and a correlation coefficient of 0.9 or better 
for the linear fit of the Scatchard plot were included. 
The Bmax appeared to be independent of Chol/PL. 
The Bmax/Kd was calculated for each assay in-
cluded in Figures 31 and 32. Its relationship to Chol/PL 
is illustrated in Figure 33. Over the entire range of 
Chol/PL, there appeared to be a trend toward an increasing 
Bmax/Kd as the Chol/PL was increased. The magnitude of 
this change was about 2-fold. 
Although the Chol/PL of control SPM and synapto-
somes were not statistically different, 0.542 +/- 0.026 (n 
= 4) and 0.556 +/- 0.013 (n = 8), respectively, it may be 
helpful to use the percent change in Chol/PL to compare the 
relative microviscosity and the biological effect, in this 
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Figure 31. The Kd for SCH23390 Binding to Bovine Caudate 
Synaptosomes as a Function of Chol/PL. 
scH23390 binding was assayed in cholesterol-depleted, 
control, and cholesterol-loaded synaptosomes. Each assay 
consisted of duplicate determinations using 0.2-0.5 nM 
[3HJ-SCH23390 and 7 concentrations of unlabelled SCH23390 
ranging from 0-5.1 nM. The Ka was calculated from the 
slope of the Scatchard plot. Each point represents an 
individual binding assay. Only assays with at least 5 
concentration points and a correlation coefficient of 0.9 
or better for the linear fit of the Scatchard plot were 
included. The Chol/PL of control synaptosomes was 0.556 
+/- 0.013 (n = 8). Chol/PL of 0.30 to 0.723 could be 
considered physiological. The error bar represents the 
mean +/- standard deviation of Ka values at control 
Chol/PL. 
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figure 32. The Bmax for SCH23390 Binding to Bovine 
Caudate Synaptosomes as a Function of Chol/PL. 
scH23390 binding was assayed in cholesterol-depleted, 
control, and cholesterol-loaded synaptosomes. Each assay 
consisted of duplicate determinations using 0.2-0.5 nM 
[3H]-SCH23390 and 7 concentratiion of unlabelled SCH23390 
ranging from 0-5.1 nM. The Bmax was calculated from the 
x-intercept of the Scatchard plot. Each point represents 
an individual binding assay. Only assays with at least 5 
concentration points and a correlation coefficient of 0.9 
or better for the linear fit of the Scatchard plot were 
included. The Chol/PL of control synaptosomes was 0.556 
+/- 0.013 (n = 8). Chol/PL of 0.30 to 0.723 could be 
considered physiological. The error bar represents the 
mean +/- standard deviation of Bmax values at control 
Chol/PL. 
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figure 33. Bmax/Kd for SCH23390 Binding to Bovine 
Caudate synaptosomes as a Function of Chol/PL. 
Each point represents the Bmax/Kd from an individual 
binding assay. The Kd and Bmax were calculated from 
the slope and X-interecept, respectively, of the Scatchard 
plot. Only assays with at least 5 concentration points and 
a correlation coefficient of 0.9 or better for the linear 
fit of the Scatchard plot were included. The Chol/PL of 
control synaptosmes was 0.556 +/- 0.013 (n = 8). Chol/PL 
of 0.30 to 0.723 could be considered physiological. The 
error bar represents the mean +/- standard deviation of 
Bmax/Kd values at control Chol/PL. 
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case the Bmax/Kd for SCH23390 binding. As the Chol/PL 
of the SPM was decreased 30%, there was a decrease in the 
relative microviscosity at both the membrane surface and in 
the core of the membrane (Figure 34). This was accompanied 
by a trend toward a decreased Bmax/Kd (Figure 35). As 
the Chol/PL was increased 30%, there was little change in 
the relative microviscosity of either region of the 
membrane (Figure 34). Also, there was little effect 
observed in Bmax/Kd (Figure 35). 
DOPAMINE-SENSITIVE ADENYLATE CYCLASE USING 
BOVINE CAUDATE MEMBRANES 
Additional aliquots of the membranes that were 
used to assess the binding of ( 3H]-SCH23390 were assayed 
for dopamine stimulation of adenylate cyclase activity. 
Four experimental sets, each including a control, three 
cholesterol-depleted, and three cholesterol-load~d mem-
branes, were assayed. For control membranes, the basal 
activity was 120.35 +/- 6.45 (n = 4) fmole cAMP formed per 
mg protein per 5 minute assay. The activity stimulated by 
100 pM dopamine was 228.57 +/- 4.58 (n = 4) fmole cAMP/mg 
protein/5 min. 
The basal activity was not strongly affected by 
changes in the Chol/PL (Figure 36). The dopamine-
stimulated activity was not affected when the Chol/PL was 
decreased (control Chol/PL= 0.556 +/- 0.013, n = 8). 
However, increasing the Chol/PL produced a decline in the 
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Figure 34. The Relative Microviscosity of the Surface and 
Hydrophobic Core of Bovine Caudate SPM as a 
Function of the Percent Change in Chol/PL. 
The relative microviscosity of the membrane surface 
(ANS, D) and core (DPH, x) were calculated from r values 
determined at 37°c. The Chol/PL for control SPM was 
o.542 +/- 0.026 (n = 4). A change in Chol/PL of -50% to 
30% could be considered physiological. 
Figure 35. Bmax/Kd for SCH23390 Binding to Bovine 
Caudate Synaptosomes as a Function of the Percent 
Change in Chol/PL 
Each point represents the Bmax/Ka for an individual 
binding experiment. The Ka and Bmax were calculated 
from the slope and X-intercept, respectively, of the 
Scatchard plot. Only assays with at least 5 concentration 
points and a correlation coefficient of 0.9 or better for 
the linear fit of the Scatchard plot were included. The 
Chol/PL for control synaptosomes was 0.556 +/- 0.013 (n = 
8). A change in Chol/PL of -50% to 30% could be considered 
physiological. 
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Figure 36. Adenylate Cyclase Activity of Bovine Caudate 
Synaptosmes as a Function of Chol/PL 
Adenylate cyclase activity was assayed in cholesterol-
depleted, control, and cholesterol-loaded synaptosomes. 
cyclic AMP was detected by radioimmunoassay. The 
stimulated activity was assayed in the presence of 100 µM 
dopamine. Each point represents the mean and standard 
deviation of 4 determinations. The Chol/PL of control 
synaptosomes was 0.556 +/- 0.013 (n = 8). Chol/PL of 0.30 
to 0.723 could be considered physiological. 
Figure 37. Percent Stimulation of Adenylate Cyclase 
Activity of Bovine caudate Synaptosomes by 
100 µM Dopamine as a Function of Chol/PL. 
Adenylate cyclase was assayed as described in Figure 36. 
The % stimulation is over the basal activity. The Chol/PL 
of control synaptosomes was 0.556 +/- 0.013 (n = 8). Chol/ 
PL of 0.30 to 0.723 could be considered physiological. 
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cAMP formed in the presence of dopamine to a value similar 
to the basal level in the absence of dopamine (Figure 36) . 
Because the basal activity was largely unchanged, the 
percent stimulation by 100 µM dopamine declined as the 
Chol/PL was increased to greater than 0.6 (Figure 37). 
The percent stimulation of adenylate cyclase ac-
tivity by 100 µM dopamine as a function of the percent 
change in Chol/PL is shown in Figure 38. Figure 39 shows 
the relative microviscosity of the surface (ANS) and hydro-
phobic core (DPH) of the membrane as a function of the 
percent change in Chol/PL. Although the relative micro-
viscosity decreased as the Chol/PL was decreased 30% 
(Figure 39), no effect on dopamine stimulation of adenylate 
cyclase activity was detected (Figure 38). As the Chol/PL 
was increased from the control, the very small changes in 
relative microviscosity of the membrane (Figure 35) were 
accompanied by a dramatic decrease in the stimulation of 
adenylate cyclase activity by 100 µM dopamine (Figure 38). 
SUMMARY OF STUDIES USING BOVINE CAUDATE MEMBRANES 
Decreasing the Chol/PL produced a steady decrease 
in the relative microviscosity of the membrane surface and 
hydrophobic core. Only a small increase in microviscosity 
was detected as the Chol/PL was increased. There appeared 
to be a trend toward a higher Kd for SCH23390 binding as 
the Chol/PL was increased (Figure 31). No change in the 
Bmax was detected (Figure 32). The Bmax/Kd appeared 
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Figure 38. The Percent Stimulation of Adenylate Cyclase 
Activity in Bovine Caudate Synaptosomes by 100 µM 
Dopamine as a Function of the Percent Change in 
Chol/PL. 
Adenylate cyclase activity was assayed in cholesterol-
depleted, control, and cholesterol-loaded synaptosomes. 
cyclic AMP was detected by radioimmunoassay. The 
stimulated activity was assayed in the presence of 100 µM 
dopamine. Each point represents the mean and standard 
deviation of 4 determinations. The Chol/PL of control 
synaptosomes was 0.556 +/- 0.013 (n = 8). A change in 
Chol/PL of -50% to 30% could be considered physiological. 
Figure 39. The Relative Microviscosity of the Surface and 
Hydrophobic Core of Bovine Caudate SPM as a 
Function of the Percent Change in Chol/PL. 
The relative microviscosity was of the membrane surface 
(ANS, O) and core (DPH, X) were calculated from r values 
determined at 37°c. The Chol/PL of control SPM was 0.542 
+/- 0.026 (n = 4). A change in Chol/PL of -50% to 30% 
could be considered physiological. 
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to decrease as the Chol/PL was decreased, and to increase 
as the Chol/PL was increased (Figure 33). Basal adenylate 
cyclase activity was unaffected by the experimentally 
produced changes in Chol/PL (Figure 36). However, that 
stimulated by 100 µM dopamine decreased as the Chol/PL was 
increased (Figure 36). This resulted in a decrease in the 
percent stimulation by dopamine as the Chol/PL was 
increased (Figure 37). 
CHAPTER V 
DISCUSSION 
The research described in this dissertation exam-
ined the influence of the molar ratio of cholesterol to 
phospholipid (Chol/PL) on synaptic membrane fluidity, and 
on selected membrane-associated functions of the dopamin-
ergic system. Modification of the synaptic ratio of cho-
lesterol to phospholipid was facilitated by a lipid trans-
fer protein. Alterations in membrane fluidity, dopamine 
uptake, o1 binding, and dopamine-stimulation of adenylate 
cyclase activity were observed over a wide range of Chol/ 
PL, some of which were beyond the physiological range. 
However, significant changes in the dopaminergic system 
were also detected within the physiological range of Chol/ 
PL. 
The following discussion will address: 1) the 
impact of changes in the synaptic Chol/PL on synaptic mem-
brane fluidity at the surface and core of the membrane; 2) 
the impact of changes in the synaptic Chol/PL on the dopa-
minergic system; and 3) the potential relevance of such 
changes within the physiological range to age- and/or 
alcohol-related changes in the dopaminergic system. 
In the present studies, the relative micro-
viscosity of both the hydrophobic core and the surface of 
148 
149 
rat whole brain SPM was affected by changes in Chol/PL in 
an unexpected manner. The relationship appeared to be 
sigmoidal, producing the greatest change in the relative 
microviscosity within the physiological range (Figures 17 
and 19). These renults suggest that synaptic membranes 
from rat exist in two distinct states of microviscosity 
which is a function of the Chol/PL. The transition between 
these states occurs over a relatively narrow range of Chol/ 
PL within the physiological range. This is supported by 
Arrhenius plots of DPH anisotropy (Figure 16) which show 
that at the physiological Chol/PL, the membranes appear to 
undergo a transition between these states such that at low 
temperature, the slope of the plot approaches that obtained 
at high Chol/PL, and at high temperature, the slope of the 
Arrhenius plot approaches that obtained at low Chol/PL. 
The presence of cholesterol-rich domains within 
the membrane may be responsible for the mentioned sigmoidal 
relationship. In model membranes, at low Chol/PL (0.25, 20 
mole%), there are pure phospholipid domains, and a choles-
terol-phospholipid phase. These domains would be readily 
detected by the ANS surface probe due to its preference for 
interaction with phosphatidylcholine (Slavik, 1982). The 
DPH probe, in theory, should not detect these two domains 
because of its presumed uniform distribution throughout the 
membrane. However, at low Chol/PL, the contribution of 
proteins to the DPH anisotropy would be greater that at 
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high Chol/PL. This could account for the independence of 
microviscosity on Chol/PL at low values. 
As the Chol/PL increases (0.43 to 0.54, 30 to 35 
mole%), the pure phospholipid phase is abolished 
{Schroeder, 1984). This is accompanied by an inhibition of 
the lateral diffusion of cholesterol (Alecia et al., 1982), 
which may indicate a marked decrease in the fluidity of the 
membrane. Also, this transition to the entirely PL-chol 
membrane may be accompanied by an overall change in the 
packing of the phospholipids within the membrane. The 
range of Chol/PL over which this phenomenon occurs in model 
membranes is similar to the Chol/PL at which a marked 
change in the relative microviscosity was observed in the 
experimental membranes used in the present studies. At 
high Chol/PL (1.0, 50 mole%), the cholesterol would begin 
to aggregate, forming irregular structures, such as in-
verted micelles, in the membrane. These structures may 
exclude both ANS and DPH. This may explain the indepen-
dence of microviscosity on Chol/PL at high values. 
Many membrane-associated synaptic functions are 
markedly affected by changes in Chol/PL or changes in 
fluidity. For example, it is known that the activity of 
such key synaptic enzymes as Na+-K+-ATPase and ligand-
stimulated adenylate cyclase are altered by changes in the 
fluidity of the membrane (Farias et al., 1975; Alivisatos 
et al., 1977; Rimon et al., 1978; Alivisatos et al., 1981; 
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Whetten et al., 1983). In addition, the binding to cholin-
ergic, seritonergic and opiate receptors, and to the GABA 
transporter are influenced markedly by membrane cholesterol 
(Heron et al., 1980a,b; Heron et al., 1981; Chweh & Leslie, 
1982; Crews et al., 1983a; North & Fleischer, 1983b). 
Presumably, there is a mechanism by which the 
central nervous system (CNS) regulates the Chol/PL within a 
narrow range in order to minimize the influence of such 
changes on neural function. The mechanism of regulation of 
the Chol/PL is unknown. However, it is possible that such 
regulation involves the synthesis of membrane precursors 
and the axonal transport of these precursors between the 
cell body and the nerve terminal. Since there is a blood 
brain barrier to plasma lipoproteins which transport cho-
lesterol and phospholipids throughout the rest of the body 
(concepts reviewed by Ochs, 1981, and Katzman, 1981, in 
Basic Neurochemistry, Chapters 22 and 25, respectively), 
such a barrier may serve to protect the brain and synaptic 
membranes from marked changes in plasma lipid levels. 
It is interesting that more marked changes in 
Chol/PL are seen in membranes outside the blood brain 
barrier in response to changes in serum levels of cho-
lesterol and phospholipids. For example, the lipid compo-
sition of erythrocyte membranes is more susceptible to 
changes in serum cholesterol levels than is the lipid 
composition of synaptic membranes (Chin et al., 1978). 
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Although the functions associated with peripheral membranes 
are important, it may be more essential to the short-term 
survival of the animal to more finely control the environ-
ment of those functions associated with CNS neural mem-
branes. 
In the present studies, the modification of 
synaptic Chol/PL was found to have a marked effect on the 
uptake of dopamine. The ~ for dopamine uptake into rat 
whole brain synaptosomes increased sharply as the Chol/PL 
was increased (Figure 25). An increase in Chol/PL of 30% 
produced a 3-fold increase in the ~ (Figure 25) . over 
the same range of Chol/PL, there was a small increase in 
the Vmax (Figure 26). These results suggest that as the 
membrane becomes more rigid, the affinity of the uptake 
transporter for dopamine decreases. At the same time, 
there is a partially compensatory increase in the maximum 
velocity. However, although the Vmax was increased, a 
higher concentration of dopamine would be required to 
achieve this maximum rate, due to the increase in ~· It 
should be noted that the increase in ~ occurs within the 
range of Chol/PL that produced the dramatic change in the 
relative microviscosity. 
At first glance, the increase in both the ~ and 
the Vmax appears unusual. 
easily in kinetic terms. 
uptake process: 
However, this is explained 
For the simplest scheme for the 
k1, k2 T + dopamine0 ut;====- T·dopamine~~~) T + dopaminein 
k_l 
the Km = k2 + k_l 
k1 
and the vmax = k 2 [T], 
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with T representing the uptake transporter. Because in the 
in vitro assay the concentration of the transporter is 
constant, the increase in the Vmax would be due to an 
increase in k 2 . This increase in k 2 will also produce 
an increase in Km· 
Perhaps a more useful index of dopamine uptake is 
the Vmax/Km (Figure 27), a first order rate constant 
for the uptake transporter at low substrate concentra-
tions. At synaptic concentrations of dopamine that are 
less than the Km, the rate of uptake will be determined 
by the VmaxlI<m· At concentrations that are greater 
than the Km, the rate of uptake will be determined by the 
Vmax (Cornish-Bowden, 1979). 
As the Chol/PL was increased 30% (within the 
physiological range), there was a 33% decrease in the 
VmaxlI<m· This suggests that as the membrane becomes 
more rigid, the rate of uptake will decrease if the 
synaptic concentration of dopamine is less than the Km· 
Because the concentration of dopamine in the synapse in not 
known, an absolute statement as to the expected effect of 
changes in Chol/PL on in vivo dopamine uptake are not 
possible. 
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Since synaptic uptake of dopamine must, by def ini-
tion, involve a transmembrane process, it is not surprising 
that the uptake would be sensitive to changes in the mem-
brane environment of the transporter. Although the mechan-
ism of the dopamine uptake process into synaptosomes is not 
known, it is presumably similar to the uptake of the other 
biogenic amines. Kinetic studies suggest that the trans-
port of norepinephrine into synaptosomes is protein-medi-
ated and coupled to the transport of Na+ (Trendelenburg, 
1981). Such a transmembrane transport protein must have 
certain structural features in order to function eff i-
ciently (Carruthers & Melchior, 1986). The protein must 
contain domains that catalyze the unidirectional transfer 
of substrates across the lipid bilayer. These domains 
could be a series of gates that are triggered as the sub-
strate moves through the protein. Alternately, the domains 
may form a channel through the protein, through which sub-
strates may pass. The transporter must also contain sub-
strate recognition sites. These sites would initiate the 
gating mechanism or open the transport channel when the 
substrate is bound. Also, regulatory domains might be 
present. Each of these domains, and the coupling between 
these domains could be modulated by changes in the lipid 
environment (Carruthers & Melchior, 1986). It is possible 
that the dopamine uptake transporter is within one of the 
pure phospholipid regions of the membrane. As the Chol/PL 
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increases, and the phospholipid domain is abolished, the 
uptake may be inhibited, due to the accompanying increase 
in the membrane microviscosity. Also, the rate of dopamine 
uptake would be dependent on the sodium gradient across the 
synaptic membrane. At low Chol/PL, the membrane may be 
more permeable to sodium ions, dissipating the gradient and 
slowing the rate of uptake. At high Chol/PL, the membrane 
may become less permeable to sodium ions, resulting in a 
greater potential difference across the membrane, increas-
ing the uptake rate. 
The present studies suggest that there is a small 
influence of Chol/PL and membrane fluidity on the binding 
of SCH23390 to the o1 receptor in bovine caudate mem-
branes. over the range of Chol/PL of 0.3 to 0.5, there was 
an decrease in the Ka for SCH23390 of about 50% (Figure 
31). Because the Bmax was unchanged (Figure 32), the 
Bmax/Ka tended to decrease as the Chol/PL decreased 
over this range. At Chol/PL above 0.5, the o1 receptor 
appears to be unaffected. 
Dopamine-stimulated adenylate cyclase is a mem-
brane-associated enzyme whose activity is stimulated 
through a multi-step process, initiated by the binding of 
dopamine to the o1 receptor. The activation of adenylate 
cyclase requires the lateral diffusion of the receptor, as 
well as the regulatory G-protein (Rimon et al., 1978). 
This type of mechanism would be expected to be affected by 
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changes in membrane fluidity. 
The present studies examined the effects of alter-
ing the Chol/PL of bovine caudate synaptosomal membranes on 
basal and dopamine-stimulated adenylate cyclase activity. 
These studies demonstrated that the activity of dopamine-
stimulated adenylated cyclase was modulated by the synaptic 
Chol/PL. If the dopamine receptor system is coupled to 
adenylate cyclase through a mobile receptor, as is epineph-
rine (Rimon et al., 1978), decreasing the relative micro-
viscosity of the membrane would be expected to enhance the 
stimulatory effect of the ligand (Rimon et al., 1978). The 
dopamine stimulation of adenylate cyclase activity was not 
affected by decreasing the membrane fluidity via decreasing 
the Chol/PL (Figures 38 and 39). The discrepancy of the 
present results with those expected of a mobile receptor 
may be due to the masking of the effect by maximally stimu-
lating the enzyme. Cholesterol loading of the synaptic 
membranes produced a marked inhibition of maximal dopamine 
stimulation of adenylate cyclase activity (Figure 36) . 
Because of the lateral movement of the G-protein required 
for activation of the enzyme, the dopamine-stimulated 
adenylate cyclase system may require a more fluid phospho-
lipid domain for optimal stimulation. When the phospho-
lipid domain is abolished by increasing the Chol/PL, the 
stimulated activity may be expected to decrease. The basal 
activity was unaffected by changes in membrane composition 
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and fluidity (Figure 36). 
The results of the present studies have demon-
strated that the transmembrane processes involved with the 
dopaminergic system, namely, the uptake of dopamine and 
dopamine stimulation of adenylate cyclase, are inhibited by 
an increase in Chol/PL. Since aging and alcohol are known 
to be associated with an increase in synaptic Chol/PL (Chin 
et al., 1978; Smith & Gerhart, 1982; Armbrecht et al., 
1983; Crews et al., 1983b; Shinitzky et al., 1983), some of 
the dopaminergic changes which are found in these condi-
tions may be due to increases in Chol/PL. Other changes 
appear to be unrelated. Specific examples of the potential 
contribution of the change in Chol/PL to age- and/or 
alcohol-associated changes in dopaminergic function are 
discussed. 
The change in dopamine uptake with normal post-
natal development as well as with aging may be explained, 
in part, by normal physiological changes in Chol/PL. 
During postnatal development, there is an increase in 
dopamine uptake, due to an increase in the Vmax (Coyle & 
Campachiaro, 1976). In the present studies, as the Chol/PL 
was decreased from the normal adult ratio to that found in 
the synaptic membranes from young animals, the Vmax 
decreased (Figure 26). This suggests that the increased 
Vmax for dopamine uptake, which occurs during development 
may be due to an increase in the number of uptake trans-
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porters per cell rather than to changes in membrane compo-
sition and fluidity. 
Studies of the effects of aging on dopamine uptake 
(Jonec & Finch, 1975) showed a 30% decrease in dopamine 
uptake at a dopamine concentration of 10 nM, which is below 
the ~ (40 nM). This decrease was attributed to a 35% 
increase in the ~· Because no change in Vmax was 
observed, the Vmaxl~ was decreased with aging. As 
would be expected, at 120 nM, which is above the ~' no 
difference was observed between the young and old animals. 
The increased ~ for dopamine uptake observed in the 
present studies as the Chol/PL was increased suggests that 
the changes in Chol/PL and membrane fluidity which occur 
during aging may be responsible, in part, for the observed 
changes in dopamine uptake. 
In addition, it appears that the age- and/or 
alcohol-related changes in dopamine stimulation of adenyl-
ate cyclase activity may be related to changes in the 
Chol/PL. During aging (Puri & Volicer, 1977; Makman et 
al., 1980; Schmidt & Thornberry, 1981) and with chronic 
ethanol treatment (Tabakoff & Hoffman, 1979; Lucchi et al., 
1983), there was a decreased sensitivity of adenylate 
cyclase for dopamine, due to a decreased efficiency of 
coupling between the receptor and the catalytic site of 
adenylate cyclase (Tabakoff & Hoffman, 1979). The present 
studies suggest that this decreased sensitivity could be 
due to age- and/or alcohol-related membrane fluidity 
changes. 
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It is difficult to correlate the present studies 
with the current literature on dopamine receptors in devel-
oping, aging, and ethanol-treated animals. Past studies 
have generally used the radioactive ligand, [ 3H]-spiper-
one, to label dopamine receptors. However, depending on 
the concentration of spiperone, the assay conditions, and 
the brain region analyzed, spiperone can label o1 , o2 , 
and serotonin receptors. There is indirect evidence, from 
studies using spiperone and a o2 specific ligand, that 
the decrease in the Bmax for spiperone binding detected 
in aged animals, may be due to the o1 receptors (Memo et 
al., 1980; Severson & Finch, 1980; Trabucchi et al., 1982; 
Missale et al., 1983). In the present studies, the Bmax 
of the o1 receptor, as assessed using SCH23390, was un-
affected by changes in membrane fluidity. Therefore, if 
the decrease in the Bmax detected in aged animals is due 
to the o1 receptors, it is unlikely that this decrease is 
due to membrane fluidity effects. 
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SUMMARY 
The research described in this dissertation 
examined the influence of the cholesterol to phospholipid 
molar ratio on synaptic membrane fluidity, and on selected 
membrane-associated functions of the dopaminergic system. 
Modifications of the synaptic cholesterol to phospholipid 
molar ratio was facilitated by a lipid transfer protein. 
synaptic membrane fluidity was assessed using l-anilino-
naphthalene-8-sulfonic acid (ANS) and l,6-diphenyl-1,3,5-
hexatriene (DPH) as probes of membrane surface and core 
fluidity, respectively. The components of dopaminergic 
function which were assessed include dopamine uptake, o1 
binding, and o1-stimulated adenylate cyclase activity. 
Alterations in membrane fluidity, dopamine uptake, o1 
binding and dopamine stimulation of adenylate cyclase 
activity were observed over a wide range of Chol/PL, some 
of which were beyond the physiological range. However, 
significant changes in the dopaminergic system were also 
detected within the physiological range of Chol/PL. 
The results of the studies described in this 
dissertation suggest that the transmembrane processes of 
the dopaminergic system, dopamine uptake and dopamine-
stimulated adenylate cyclase activity, are highly sensitive 
to changes in the Chol/PL of synaptic and synaptosomal mem-
branes within the physiological range of Chol/PL. For 
example, as the fluidity of the membrane was decreased by 
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increasing the Chol/PL 30% above the normal value, the ~ 
for dopamine uptake was increased 3-fold. such an increase 
also caused a 33% decrease in the Vmax/~, the first 
order rate constant for dopamine uptake at low concentra-
tions of dopamine. In addition, cholesterol loading of the 
synaptic membranes produced a marked inhibition (80-90%) of 
the maximal stimulation of adenylate cyclase by dopamine. 
In contrast to the highly sensitive transmembrane processes 
of the dopaminergic system, D1 binding was less sensitive 
to the effects of changes in membrane Chol/PL and fluid-
ity. As the Chol/PL was increased 33% above the control 
value, the binding of SCH23390 to the o1 site was un-
affected. 
In light of the findings presented here, it 
appears likely that some of the changes in dopaminergic 
function which are known to accompany aging and chronic 
alcohol consumption can be explained by the age- and 
alcohol-associated changes in the synaptic Chol/PL and 
fluidity. In particular, it seems likely that the age-
associated decrease in Vmaxl~ for uptake and decreased 
sensitivity of adenylate cyclase for dopamine could be 
related to the increased Chol/PL in those animals. The 
decreased efficiency of coupling of the dopamine receptor 
with the catalytic site of adenylate cyclase in alcohol-
treated animals might similarly be explained. These 
observations are consistent with reports from other lab-
162 
oratories of cholesterol inhibition of diffusion-controlled 
enzyme systems. In contrast, it does not seem likely that 
altered synaptic Chol/PL and fluidity contribute signifi-
cantly to physiological changes in D1 binding. 
The results presented here provide significant new 
information about how synaptic membrane composition and 
fluidity affect synaptic function. In addition, this new 
information may contribute to our understanding of the 
causes of age- and alcohol-associated changes in CNS 
function. 
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